| 1 |
Gulati AS, Nicholson MR, Khoruts A, Kahn SA. Fecal Microbiota Transplantation Across the Lifespan: Balancing Efficacy, Safety, and Innovation. Am J Gastroenterol 2023;118:435-9. [PMID: 36580630 DOI: 10.14309/ajg.0000000000002167] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 2 |
Liu YY. Controlling the human microbiome. Cell Syst 2023;14:135-59. [PMID: 36796332 DOI: 10.1016/j.cels.2022.12.010] [Reference Citation Analysis]
|
| 3 |
Pu Y, Fan X, Zhang Z, Guo Z, Pan Q, Gao W, Luo K, He B. Harnessing polymer-derived drug delivery systems for combating inflammatory bowel disease. J Control Release 2023;354:1-18. [PMID: 36566845 DOI: 10.1016/j.jconrel.2022.12.044] [Reference Citation Analysis]
|
| 4 |
Nicolaides S, Boussioutas A. Immune-Related Adverse Events of the Gastrointestinal System. Cancers (Basel) 2023;15. [PMID: 36765649 DOI: 10.3390/cancers15030691] [Reference Citation Analysis]
|
| 5 |
Xie X, Li Q, Jia L, Yuan H, Guo T, Meng T. Multishell Colloidosome Platform with Sequential Gastrointestinal Resistance for On-Demand Probiotic Delivery. Adv Healthc Mater 2023;:e2202954. [PMID: 36652659 DOI: 10.1002/adhm.202202954] [Reference Citation Analysis]
|
| 6 |
Han TR, Yang WJ, Tan QH, Bai S, Zhong H, Tai Y, Tong H. Gut microbiota therapy for nonalcoholic fatty liver disease: Evidence from randomized clinical trials. Front Microbiol 2022;13:1004911. [PMID: 36726574 DOI: 10.3389/fmicb.2022.1004911] [Reference Citation Analysis]
|
| 7 |
He R, Chen J, Zhao Z, Shi C, Du Y, Yi M, Feng L, Peng Q, Cui Z, Gao R, Wang H, Huang Y, Liu Z, Wang C. T-cell activation Rho GTPase-activating protein maintains intestinal homeostasis by regulating intestinal T helper cells differentiation through the gut microbiota. Front Microbiol 2022;13:1030947. [PMID: 36704549 DOI: 10.3389/fmicb.2022.1030947] [Reference Citation Analysis]
|
| 8 |
Hao S, Yang S, Zhang N, Cheng H. Fecal Microbiota Transplantation Research over the Past Decade: Current Status and Trends. Can J Infect Dis Med Microbiol 2023;2023:6981721. [PMID: 36654766 DOI: 10.1155/2023/6981721] [Reference Citation Analysis]
|
| 9 |
Ting NL, Yu J. Microbiota in Cancer Immunotherapy: The Next Milestone of Immuno-oncology? Microbiome in Gastrointestinal Cancer 2023. [DOI: 10.1007/978-981-19-4492-5_17] [Reference Citation Analysis]
|
| 10 |
Zhao M, Jiang G, Zhou H, Li J, Xiang W, Li S, Wang H, Zhou J. Gut microbiota: a potential target for improved cancer therapy. J Cancer Res Clin Oncol 2023;149:541-52. [PMID: 36550389 DOI: 10.1007/s00432-022-04546-5] [Reference Citation Analysis]
|
| 11 |
Kuang G, Zhang Q, Jia J, Yu Y. Freezing biological organisms for biomedical applications. Smart Medicine 2022. [DOI: 10.1002/smmd.20220034] [Reference Citation Analysis]
|
| 12 |
Willman J, Willman M, Reddy R, Fusco A, Sriram S, Mehkri Y, Charles J, Goeckeritz J, Lucke-Wold B. Gut microbiome and neurosurgery: Implications for treatment. Clin Transl Discov 2022;2:e139. [PMID: 36268259 DOI: 10.1002/ctd2.139] [Reference Citation Analysis]
|
| 13 |
Aslam N, Lo SW, Sikafi R, Barnes T, Segal J, Smith PJ, Limdi JK. A review of the therapeutic management of ulcerative colitis. Therap Adv Gastroenterol 2022;15:17562848221138160. [PMID: 36478780 DOI: 10.1177/17562848221138160] [Reference Citation Analysis]
|
| 14 |
Ma Y, Ke D, Li D, Zhang Q. Donors' experiences and attitudes of fecal microbiota transplantation: An empirical bioethics study from China. iMeta 2022. [DOI: 10.1002/imt2.62] [Reference Citation Analysis]
|
| 15 |
Elokil AA, Chen W, Mahrose K, Elattrouny MM, Abouelezz KFM, Ahmad HI, Liu H, Elolimy AA, Mandouh MI, Abdelatty AM, Li S. Early life microbiota transplantation from highly feed-efficient broiler improved weight gain by reshaping the gut microbiota in laying chicken. Front Microbiol 2022;13. [DOI: 10.3389/fmicb.2022.1022783] [Reference Citation Analysis]
|
| 16 |
Wang JG, Liang Q, Dou HH, Ou Y. The global incidence of adverse events associated with fecal microbiota transplantation in children over the past 20 years: A systematic review and meta-analysis. J Gastroenterol Hepatol 2022;37:2031-8. [PMID: 36066910 DOI: 10.1111/jgh.15996] [Reference Citation Analysis]
|
| 17 |
Masi L, Ciuffini C, Petito V, Pisani LF, Lopetuso LR, Graziani C, Pugliese D, Laterza L, Puca P, Di Vincenzo F, Pizzoferrato M, Napolitano D, Turchini L, Amatucci V, Schiavoni E, Privitera G, Minordi LM, Mentella MC, Papa A, Armuzzi A, Gasbarrini A, Scaldaferri F. Innovative, complementary and alternative therapy in inflammatory bowel diseases: A broad 2020s update. Front Gastroenterol 2022;1. [DOI: 10.3389/fgstr.2022.1022530] [Reference Citation Analysis]
|
| 18 |
Yip A, Smith-Roberge J, Khorasani SH, Aucoin MG, Ingalls BP. Calibrating spatiotemporal models of microbial communities to microscopy data: A review. PLoS Comput Biol 2022;18:e1010533. [PMID: 36227846 DOI: 10.1371/journal.pcbi.1010533] [Reference Citation Analysis]
|
| 19 |
Boix-Amorós A, Monaco H, Sambataro E, Clemente JC. Novel technologies to characterize and engineer the microbiome in inflammatory bowel disease. Gut Microbes 2022;14:2107866. [PMID: 36104776 DOI: 10.1080/19490976.2022.2107866] [Reference Citation Analysis]
|
| 20 |
Vaughn BP, Fischer M, Kelly CR, Allegretti JR, Graiziger C, Thomas J, McClure E, Kabage AJ, Khoruts A. Effectiveness and Safety of Colonic and Capsule Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection. Clin Gastroenterol Hepatol 2022:S1542-3565(22)00880-1. [PMID: 36126907 DOI: 10.1016/j.cgh.2022.09.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 21 |
Wang Y, Zhang S, Borody TJ, Zhang F. Encyclopedia of fecal microbiota transplantation: a review of effectiveness in the treatment of 85 diseases. Chinese Medical Journal 2022;Publish Ahead of Print. [DOI: 10.1097/cm9.0000000000002339] [Reference Citation Analysis]
|
| 22 |
Mitra S, Sultana SA, Prova SR, Uddin TM, Islam F, Das R, Nainu F, Sartini S, Chidambaram K, Alhumaydhi FA, Emran TB, Simal-Gandara J. Investigating forthcoming strategies to tackle deadly superbugs: current status and future vision. Expert Rev Anti Infect Ther 2022. [PMID: 36069241 DOI: 10.1080/14787210.2022.2122442] [Reference Citation Analysis]
|
| 23 |
Liu Z, Good BH. Dynamics of bacterial recombination in the human gut microbiome.. [DOI: 10.1101/2022.08.24.505183] [Reference Citation Analysis]
|
| 24 |
Dong Y, Xu T, Xiao G, Hu Z, Chen J. Opportunities and challenges for synthetic biology in the therapy of inflammatory bowel disease. Front Bioeng Biotechnol 2022;10:909591. [DOI: 10.3389/fbioe.2022.909591] [Reference Citation Analysis]
|
| 25 |
Cao C, Wang L, Ai C, Gong G, Wang Z, Huang L, Song S, Zhu B. Impact of Lycium barbarum arabinogalactan on the fecal metabolome in a DSS-induced chronic colitis mouse model. Food Funct 2022. [PMID: 35912853 DOI: 10.1039/d2fo01283a] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 26 |
Yang L, Hung LY, Zhu Y, Ding S, Margolis KG, Leong KW. Material Engineering in Gut Microbiome and Human Health. Research 2022;2022:1-32. [DOI: 10.34133/2022/9804014] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 27 |
Wu F, Liu J. Decorated bacteria and the application in drug delivery. Adv Drug Deliv Rev 2022;188:114443. [PMID: 35817214 DOI: 10.1016/j.addr.2022.114443] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 28 |
Yang J, Yang H, Li Y. The triple interactions between gut microbiota, mycobiota and host immunity. Crit Rev Food Sci Nutr 2022;:1-21. [PMID: 35776086 DOI: 10.1080/10408398.2022.2094888] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 29 |
Ting NL, Lau HC, Yu J. Cancer pharmacomicrobiomics: targeting microbiota to optimise cancer therapy outcomes. Gut 2022;71:1412-25. [PMID: 35277453 DOI: 10.1136/gutjnl-2021-326264] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 25.0] [Reference Citation Analysis]
|
| 30 |
Li Z, Ke H, Lin Q, Shen Z, Chen Y. Global trends in gut microbiota and clostridioides difficile infection research: A visualized study. J Infect Public Health 2022;15:806-15. [PMID: 35759806 DOI: 10.1016/j.jiph.2022.06.011] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 31 |
Zheng L, Ji YY, Wen XL, Duan SL. Fecal microbiota transplantation in the metabolic diseases: Current status and perspectives. World J Gastroenterol 2022; 28(23): 2546-2560 [DOI: 10.3748/wjg.v28.i23.2546] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 32 |
Guo Q, Qin H, Liu X, Zhang X, Chen Z, Qin T, Chang L, Zhang W. The Emerging Roles of Human Gut Microbiota in Gastrointestinal Cancer. Front Immunol 2022;13:915047. [DOI: 10.3389/fimmu.2022.915047] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 33 |
Tuniyazi M, Li S, Hu X, Fu Y, Zhang N. The Role of Early Life Microbiota Composition in the Development of Allergic Diseases. Microorganisms 2022;10:1190. [PMID: 35744708 DOI: 10.3390/microorganisms10061190] [Reference Citation Analysis]
|
| 34 |
Zhang J, Liang Z, Ding Kao R, Han J, Du M, Ahmad AA, Wang S, Salekdeh GH, Long R, Yan P, Ding X. Maternal Fecal Microbes Contribute to Shaping the Early Life Assembly of the Intestinal Microbiota of Co-inhabiting Yak and Cattle Calves. Front Microbiol 2022;13:916735. [DOI: 10.3389/fmicb.2022.916735] [Reference Citation Analysis]
|
| 35 |
Liu W, Guo X, Chen Y, Tang Y, Xiao H, Wang Y, Li S, Zhou Z. Effects of choline chloride on intestinal microbiota and its association with liver fat accumulation in zebrafish. Aquaculture Reports 2022;24:101096. [DOI: 10.1016/j.aqrep.2022.101096] [Reference Citation Analysis]
|
| 36 |
Ke S, Weiss ST, Liu Y. Rejuvenating the human gut microbiome. Trends in Molecular Medicine 2022. [DOI: 10.1016/j.molmed.2022.05.005] [Reference Citation Analysis]
|
| 37 |
He Z, Ma Y, Yang S, Zhang S, Liu S, Xiao J, Wang Y, Wang W, Yang H, Li S, Cao Z. Gut microbiota-derived ursodeoxycholic acid from neonatal dairy calves improves intestinal homeostasis and colitis to attenuate extended-spectrum β-lactamase-producing enteroaggregative Escherichia coli infection. Microbiome 2022;10. [DOI: 10.1186/s40168-022-01269-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 38 |
Pal R, Athamneh AIM, Deshpande R, Ramirez JAR, Adu KT, Muthuirulan P, Pawar S, Biazzo M, Apidianakis Y, Sundekilde UK, de la Fuente-Nunez C, Martens MG, Tegos GP, Seleem MN. Probiotics: insights and new opportunities for Clostridioides difficile intervention. Crit Rev Microbiol 2022;:1-21. [PMID: 35574602 DOI: 10.1080/1040841X.2022.2072705] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 39 |
Shor EK, Brown SP, Freeman DA. Bacteria and Bellicosity: Photoperiodic Shifts in Gut Microbiota Drive Seasonal Aggressive Behavior in Male Siberian Hamsters. J Biol Rhythms 2022;:7487304221092105. [PMID: 35502701 DOI: 10.1177/07487304221092105] [Reference Citation Analysis]
|
| 40 |
Lam S, Bai X, Shkoporov AN, Park H, Wu X, Lan P, Zuo T. Roles of the gut virome and mycobiome in faecal microbiota transplantation. The Lancet Gastroenterology & Hepatology 2022;7:472-84. [DOI: 10.1016/s2468-1253(21)00303-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 41 |
Jing Y, Bai F, Wang L, Yang D, Yan Y, Wang Q, Zhu Y, Yu Y, Chen Z. Fecal Microbiota Transplantation Exerts Neuroprotective Effects in a Mouse Spinal Cord Injury Model by Modulating the Microenvironment at the Lesion Site. Microbiol Spectr 2022;:e0017722. [PMID: 35467388 DOI: 10.1128/spectrum.00177-22] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 42 |
Nagao-Kitamoto H, Kitamoto S, Kamada N. Inflammatory bowel disease and carcinogenesis. Cancer Metastasis Rev 2022. [PMID: 35416564 DOI: 10.1007/s10555-022-10028-4] [Reference Citation Analysis]
|
| 43 |
Ostrowski B, Krawczyk B. Breastfeeding as a regulating factor of the development of the intestinal microbiome in the early stages of life. Eur Food Res Technol. [DOI: 10.1007/s00217-022-04012-z] [Reference Citation Analysis]
|
| 44 |
Chidambaram SB, Rathipriya AG, Mahalakshmi AM, Sharma S, Hediyal TA, Ray B, Sunanda T, Rungratanawanich W, Kashyap RS, Qoronfleh MW, Essa MM, Song BJ, Monaghan TM. The Influence of Gut Dysbiosis in the Pathogenesis and Management of Ischemic Stroke. Cells 2022;11:1239. [PMID: 35406804 DOI: 10.3390/cells11071239] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 45 |
He Z, Ma Y, Chen X, Liu S, Xiao J, Wang Y, Wang W, Yang H, Li S, Cao Z. Protective Effects of Intestinal Gallic Acid in Neonatal Dairy Calves Against Extended-Spectrum β-lactamase Producing Enteroaggregative Escherichia coli Infection: Modulating Intestinal Homeostasis and Colitis. Front Nutr 2022;9:864080. [DOI: 10.3389/fnut.2022.864080] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 46 |
Khan R, Roy N, Ali H, Naeem M, Sakai E. Fecal Microbiota Transplants for Inflammatory Bowel Disease Treatment: Synthetic- and Engineered Communities-Based Microbiota Transplants Are the Future. Gastroenterology Research and Practice 2022;2022:1-9. [DOI: 10.1155/2022/9999925] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 47 |
Lu Q, Fu Y, Li H. Berberine and its derivatives represent as the promising therapeutic agents for inflammatory disorders. Pharmacol Rep 2022. [PMID: 35083737 DOI: 10.1007/s43440-021-00348-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 48 |
Ramires LC, Santos GS, Ramires RP, da Fonseca LF, Jeyaraman M, Muthu S, Lana AV, Azzini G, Smith CS, Lana JF. The Association between Gut Microbiota and Osteoarthritis: Does the Disease Begin in the Gut? Int J Mol Sci 2022;23:1494. [PMID: 35163417 DOI: 10.3390/ijms23031494] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 49 |
Chauhan NS. Microbiome, Therapeutics Application and Epigenetics: Conclusion and Future Prospective. Comprehensive Gut Microbiota 2022. [DOI: 10.1016/b978-0-12-819265-8.00025-5] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 50 |
Li N, Tan X, Yang Q. Recent Progress on Strategies and Applications of Imaging for Intestinal Microflora. Chinese Journal of Organic Chemistry 2022;42:1375. [DOI: 10.6023/cjoc202112022] [Reference Citation Analysis]
|
| 51 |
Banik SP, Sehgal S, Ghosh RB, Das A. Impact of the gut microbiome on human health and diseases. Microbiome, Immunity, Digestive Health and Nutrition 2022. [DOI: 10.1016/b978-0-12-822238-6.00026-1] [Reference Citation Analysis]
|
| 52 |
Yoshino O, Ono Y, Hiraoka T. Gut microbiota and endometriosis. Immunology of Endometriosis 2022. [DOI: 10.1016/b978-0-12-820661-4.00011-x] [Reference Citation Analysis]
|
| 53 |
Chen Y, Li Y. Metabolic reprogramming and immunity in cancer. Cancer Immunology and Immunotherapy 2022. [DOI: 10.1016/b978-0-12-823397-9.00006-5] [Reference Citation Analysis]
|
| 54 |
Kelly-Goss MR, Badran YR, Dougan M. Update on Immune Checkpoint Inhibitor Enterocolitis. Curr Gastroenterol Rep 2022;24:171-81. [PMID: 36264425 DOI: 10.1007/s11894-022-00852-7] [Reference Citation Analysis]
|
| 55 |
Torres-miranda A, Vega-sagardía M, Garrido D. Probiotics, Microbiome and the Concept of Cross-Feeding. Comprehensive Gut Microbiota 2022. [DOI: 10.1016/b978-0-12-819265-8.00055-3] [Reference Citation Analysis]
|
| 56 |
Oniyangi AG, Nazir A. Microbiome: A Novel Therapeutics in Cancer Management. Comprehensive Gut Microbiota 2022. [DOI: 10.1016/b978-0-12-819265-8.00004-8] [Reference Citation Analysis]
|
| 57 |
Chen S, Luo S, Yan C. Gut Microbiota Implications for Health and Welfare in Farm Animals: A Review. Animals (Basel) 2021;12:93. [PMID: 35011199 DOI: 10.3390/ani12010093] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 58 |
Yang YP, Zhang XY, Cui BT, Zhang H, Wu ZF, Tan X, Cheng W, Zhu X, Zhang FM, Qin HL, Wei H. Preclinical safety, effectiveness evaluation, and screening of functional bacteria for fecal microbiota transplantation based on germ-free animals. World J Meta-Anal 2021; 9(6): 496-504 [DOI: 10.13105/wjma.v9.i6.496] [Reference Citation Analysis]
|
| 59 |
Zhang Y, Xue X, Su S, Zhou H, Jin Y, Shi Y, Lin J, Wang J, Li X, Yang G, Philpott JR, Liang J. Patients and physicians' attitudes change on fecal microbiota transplantation for inflammatory bowel disease over the past 3 years. Ann Transl Med 2021;9:1619. [PMID: 34926663 DOI: 10.21037/atm-21-3683] [Reference Citation Analysis]
|
| 60 |
Valeri F, dos Santos Guilherme M, He F, Stoye NM, Schwiertz A, Endres K. Impact of the Age of Cecal Material Transfer Donors on Alzheimer’s Disease Pathology in 5xFAD Mice. Microorganisms 2021;9:2548. [DOI: 10.3390/microorganisms9122548] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 61 |
Wu J, Cui X, Ke PC, Mortimer M, Wang X, Bao L, Chen C. Nanomaterials as novel agents for amelioration of Parkinson’s disease. Nano Today 2021;41:101328. [DOI: 10.1016/j.nantod.2021.101328] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 62 |
Aparecida Dos Reis Louzano S, de Moura E Dias M, Lopes da Conceição L, Antônio de Oliveira Mendes T, Gouveia Peluzio MDC. Ceftriaxone causes dysbiosis and changes intestinal structure in adjuvant obesity treatment. Pharmacol Rep 2021. [PMID: 34757518 DOI: 10.1007/s43440-021-00336-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 63 |
Yan C, Xiao J, Li Z, Liu H, Zhao X, Liu J, Chen S, Zhao X. Exogenous Fecal Microbial Transplantation Alters Fearfulness, Intestinal Morphology, and Gut Microbiota in Broilers. Front Vet Sci 2021;8:706987. [PMID: 34660756 DOI: 10.3389/fvets.2021.706987] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 64 |
Zhao J, Yin X, Dong Z, Wang S, Li J, Dong D, Shao T. Using γ-ray irradiation and epiphytic microbiota inoculation to separate the effects of chemical and microbial factors on fermentation quality and bacterial community of ensiled Pennisetum giganteum. J Appl Microbiol 2021. [PMID: 34623726 DOI: 10.1111/jam.15323] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 65 |
King WL, Kaminsky LM, Gannett M, Thompson GL, Kao-Kniffin J, Bell TH. Soil salinization accelerates microbiome stabilization in iterative selections for plant performance. New Phytol 2021. [PMID: 34614202 DOI: 10.1111/nph.17774] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 66 |
Zhao J, Yin X, Wang S, Li J, Shao T. Separating the effects of chemical and microbial factors on fermentation quality and bacterial community of Napier grass silage by using gamma-ray irradiation and epiphytic microbiota transplantation. Animal Feed Science and Technology 2021;280:115082. [DOI: 10.1016/j.anifeedsci.2021.115082] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 67 |
Liu Y, Alnababtah K, Cook S, Yu Y. Healthcare providers' perception of faecal microbiota transplantation with clostridium difficile infection and inflammatory bowel disease: a quantitative systematic review. Therap Adv Gastroenterol 2021;14:17562848211042679. [PMID: 34567271 DOI: 10.1177/17562848211042679] [Reference Citation Analysis]
|
| 68 |
Chidambaram SB, Essa MM, Rathipriya AG, Bishir M, Ray B, Mahalakshmi AM, Tousif AH, Sakharkar MK, Kashyap RS, Friedland RP, Monaghan TM. Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle. Pharmacol Ther 2021;:107988. [PMID: 34536490 DOI: 10.1016/j.pharmthera.2021.107988] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 69 |
Rosa F, Michelotti TC, St-Pierre B, Trevisi E, Osorio JS. Early Life Fecal Microbiota Transplantation in Neonatal Dairy Calves Promotes Growth Performance and Alleviates Inflammation and Oxidative Stress during Weaning. Animals (Basel) 2021;11:2704. [PMID: 34573670 DOI: 10.3390/ani11092704] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 70 |
Li Z, Wang Y, Liu J, Rawding P, Bu J, Hong S, Hu Q. Chemically and Biologically Engineered Bacteria-Based Delivery Systems for Emerging Diagnosis and Advanced Therapy. Adv Mater 2021;33:e2102580. [PMID: 34347325 DOI: 10.1002/adma.202102580] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 12.5] [Reference Citation Analysis]
|
| 71 |
Abuaish S, Al-Otaibi NM, Abujamel TS, Alzahrani SA, Alotaibi SM, AlShawakir YA, Aabed K, El-Ansary A. Fecal Transplant and Bifidobacterium Treatments Modulate Gut Clostridium Bacteria and Rescue Social Impairment and Hippocampal BDNF Expression in a Rodent Model of Autism. Brain Sci 2021;11:1038. [PMID: 34439657 DOI: 10.3390/brainsci11081038] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 72 |
Zhuang H, Jing N, Wang L, Jiang G, Liu Z. Jujube Powder Enhances Cyclophosphamide Efficiency against Murine Colon Cancer by Enriching CD8+ T Cells While Inhibiting Eosinophilia. Nutrients 2021;13:2700. [PMID: 34444860 DOI: 10.3390/nu13082700] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 73 |
Mejía-granados DM, Villasana-salazar B, Lozano-garcía L, Cavalheiro EA, Striano P. Gut-microbiota-directed strategies to treat epilepsy: clinical and experimental evidence. Seizure 2021;90:80-92. [DOI: 10.1016/j.seizure.2021.03.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 74 |
Wang M, Cao J, Gong C, Amakye WK, Yao M, Ren J. Exploring the microbiota-Alzheimer's disease linkage using short-term antibiotic treatment followed by fecal microbiota transplantation. Brain Behav Immun 2021;96:227-38. [PMID: 34111528 DOI: 10.1016/j.bbi.2021.06.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 75 |
Włodarczyk M, Śliżewska K. Obesity as the 21st Century's major disease: The role of probiotics and prebiotics in prevention and treatment. Food Bioscience 2021;42:101115. [DOI: 10.1016/j.fbio.2021.101115] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 76 |
Yue Q, Cai M, Xiao B, Zhan Q, Zeng C. The Microbiota-Gut-Brain Axis and Epilepsy. Cell Mol Neurobiol 2021. [PMID: 34279746 DOI: 10.1007/s10571-021-01130-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 77 |
He Y, Jin X, Wang H, Dai H, Lu X, Zhao J, Zhang H, Chen W, Wang G. The emerging role of the gut microbiome in polycystic ovary syndrome. F&S Reviews 2021;2:214-26. [DOI: 10.1016/j.xfnr.2021.03.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 78 |
Hayase E, Jenq RR. Role of the intestinal microbiome and microbial-derived metabolites in immune checkpoint blockade immunotherapy of cancer. Genome Med 2021;13:107. [PMID: 34162429 DOI: 10.1186/s13073-021-00923-w] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 79 |
Deng J, Angulo MT, Saavedra S. Generalizing game-changing species across microbial communities. ISME Commun 2021;1:22. [PMID: 36737668 DOI: 10.1038/s43705-021-00022-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 80 |
Rajeev R, Seethalakshmi PS, Jena PK, Prathiviraj R, Kiran GS, Selvin J. Gut microbiome responses in the metabolism of human dietary components: Implications in health and homeostasis. Crit Rev Food Sci Nutr 2021;:1-17. [PMID: 34016000 DOI: 10.1080/10408398.2021.1916429] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 81 |
Kim JH, Kim K, Kim W. Gut microbiota restoration through fecal microbiota transplantation: a new atopic dermatitis therapy. Exp Mol Med 2021;53:907-16. [PMID: 34017060 DOI: 10.1038/s12276-021-00627-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 82 |
Hesta M, Costa M. How Can Nutrition Help with Gastrointestinal Tract-Based Issues? Vet Clin North Am Equine Pract 2021;37:63-87. [PMID: 33820610 DOI: 10.1016/j.cveq.2020.12.007] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 83 |
Doering T, Wall M, Putchim L, Rattanawongwan T, Schroeder R, Hentschel U, Roik A. Towards enhancing coral heat tolerance: a "microbiome transplantation" treatment using inoculations of homogenized coral tissues. Microbiome 2021;9:102. [PMID: 33957989 DOI: 10.1186/s40168-021-01053-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 25] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 84 |
Sugita K, Shima A, Takahashi K, Matsuda Y, Miyajima M, Hirokawa M, Kondo H, Kimura J, Ishihara G, Ohmori K. Successful outcome after a single endoscopic fecal microbiota transplantation in a Shiba dog with non-responsive enteropathy during the treatment with chlorambucil. J Vet Med Sci 2021;83:984-9. [PMID: 33896875 DOI: 10.1292/jvms.21-0063] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 85 |
Zhu J, Wang Q, Mei Z. Preliminary study on the pathogenesis of anal fistula.. [DOI: 10.1101/2021.04.15.21254769] [Reference Citation Analysis]
|
| 86 |
Gal A, Barko PC, Biggs PJ, Gedye KR, Midwinter AC, Williams DA, Burchell RK, Pazzi P. One dog's waste is another dog's wealth: A pilot study of fecal microbiota transplantation in dogs with acute hemorrhagic diarrhea syndrome. PLoS One 2021;16:e0250344. [PMID: 33872339 DOI: 10.1371/journal.pone.0250344] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 87 |
Bulgakova S, Romanchuk N. Gut Microbiome and Osteoporosis: Pathogenetic Relationship and Perspectives of Therapeutic Interventions. BSP 2021;7:121-138. [DOI: 10.33619/2414-2948/65/16] [Reference Citation Analysis]
|
| 88 |
Gaowa N, Li W, Murphy B, Cox MS. The Effects of Artificially Dosed Adult Rumen Contents on Abomasum Transcriptome and Associated Microbial Community Structure in Calves. Genes (Basel) 2021;12:424. [PMID: 33809523 DOI: 10.3390/genes12030424] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 89 |
Chen H, Shen L, Liu Y, Ma X, Long L, Ma X, Ma L, Chen Z, Lin X, Si L, Chen X. Strength Exercise Confers Protection in Central Nervous System Autoimmunity by Altering the Gut Microbiota. Front Immunol 2021;12:628629. [PMID: 33796102 DOI: 10.3389/fimmu.2021.628629] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 90 |
Qiu K, Anselmo AC. Batch Culture Formulation of Live Biotherapeutic Products. Adv Ther (Weinh) 2021;4:2000226. [PMID: 33709021 DOI: 10.1002/adtp.202000226] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 91 |
Staley C, Halaweish H, Graiziger C, Hamilton MJ, Kabage AJ, Galdys AL, Vaughn BP, Vantanasiri K, Suryanarayanan R, Sadowsky MJ, Khoruts A. Lower endoscopic delivery of freeze-dried intestinal microbiota results in more rapid and efficient engraftment than oral administration. Sci Rep 2021;11:4519. [PMID: 33633264 DOI: 10.1038/s41598-021-84152-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 92 |
Su Y, Li X, Li D, Sun J. Fecal Microbiota Transplantation Shows Marked Shifts in the Multi-Omic Profiles of Porcine Post-weaning Diarrhea. Front Microbiol 2021;12:619460. [PMID: 33708182 DOI: 10.3389/fmicb.2021.619460] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 93 |
Chang CC, Hayase E, Jenq RR. The role of microbiota in allogeneic hematopoietic stem cell transplantation. Expert Opin Biol Ther 2021;21:1121-31. [PMID: 33412949 DOI: 10.1080/14712598.2021.1872541] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 94 |
Kim HS, Whon TW, Sung H, Jeong YS, Jung ES, Shin NR, Hyun DW, Kim PS, Lee JY, Lee CH, Bae JW. Longitudinal evaluation of fecal microbiota transplantation for ameliorating calf diarrhea and improving growth performance. Nat Commun 2021;12:161. [PMID: 33420064 DOI: 10.1038/s41467-020-20389-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 95 |
Enck K, Banks S, Yadav H, Welker ME, Opara EC. Development of a Novel Oral Delivery Vehicle for Probiotics. Curr Pharm Des 2020;26:3134-40. [PMID: 32039674 DOI: 10.2174/1381612826666200210111925] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 96 |
Sommermeyer H, Piątek J. Treatment of CDI. Clostridioides difficile 2021. [DOI: 10.1007/978-3-030-81100-6_8] [Reference Citation Analysis]
|
| 97 |
Bazzocchi G, Balloni M, Turroni S. Microbiome and Chronic Pelvic Pain. Urodynamics, Neurourology and Pelvic Floor Dysfunctions 2021. [DOI: 10.1007/978-3-030-56387-5_11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 98 |
J Sadowsky M, Erickson R, Wang P, J Hamilton M, Hoo M, Kaiser T, Fryxell K, Khoruts A. Inactivation of Clostridioides Difficile Spores in Carpeting and Upholstery to Reduce Disease Recurrence in Households and Nursing Care Facilities. J Pub Health Issue Pract 2021;5. [DOI: 10.33790/jphip1100189] [Reference Citation Analysis]
|
| 99 |
Khoruts A, Staley C, Sadowsky MJ. Faecal microbiota transplantation for Clostridioides difficile: mechanisms and pharmacology. Nat Rev Gastroenterol Hepatol 2021;18:67-80. [PMID: 32843743 DOI: 10.1038/s41575-020-0350-4] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 27.5] [Reference Citation Analysis]
|
| 100 |
Zhang Y, Wang Z, Peng J, Gerner ST, Yin S, Jiang Y. Gut microbiota-brain interaction: An emerging immunotherapy for traumatic brain injury. Exp Neurol 2021;337:113585. [PMID: 33370556 DOI: 10.1016/j.expneurol.2020.113585] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 101 |
Tang J, Xu L, Zeng Y, Gong F. Effect of gut microbiota on LPS-induced acute lung injury by regulating the TLR4/NF-kB signaling pathway. Int Immunopharmacol 2021;91:107272. [PMID: 33360370 DOI: 10.1016/j.intimp.2020.107272] [Cited by in Crossref: 62] [Cited by in F6Publishing: 69] [Article Influence: 20.7] [Reference Citation Analysis]
|
| 102 |
Bao CL, Liu SZ, Shang ZD, Liu YJ, Wang J, Zhang WX, Dong B, Cao YH. Bacillus amyloliquefaciens TL106 protects mice against enterohaemorrhagic Escherichia coli O157:H7-induced intestinal disease through improving immune response, intestinal barrier function and gut microbiota. J Appl Microbiol 2021;131:470-84. [PMID: 33289241 DOI: 10.1111/jam.14952] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 103 |
Carbone EA, D'Amato P, Vicchio G, De Fazio P, Segura-Garcia C. A systematic review on the role of microbiota in the pathogenesis and treatment of eating disorders. Eur Psychiatry 2020;64:e2. [PMID: 33416044 DOI: 10.1192/j.eurpsy.2020.109] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 104 |
Niina A, Kibe R, Suzuki R, Yuchi Y, Teshima T, Matsumoto H, Kataoka Y, Koyama H. Fecal microbiota transplantation as a new treatment for canine inflammatory bowel disease. Biosci Microbiota Food Health 2021;40:98-104. [PMID: 33996366 DOI: 10.12938/bmfh.2020-049] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 105 |
Jing Y, Bai F, Yu Y. Spinal cord injury and gut microbiota: A review. Life Sci 2021;266:118865. [PMID: 33301807 DOI: 10.1016/j.lfs.2020.118865] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 106 |
Collyer R, Clancy A, Borody T. Faecal microbiota transplantation alleviates symptoms of depression in individuals with irritable bowel syndrome: A case series. Medicine in Microecology 2020;6:100029. [DOI: 10.1016/j.medmic.2020.100029] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 107 |
Su X, Yin X, Liu Y, Yan X, Zhang S, Wang X, Lin Z, Zhou X, Gao J, Wang Z, Zhang Q. Gut Dysbiosis Contributes to the Imbalance of Treg and Th17 Cells in Graves' Disease Patients by Propionic Acid. J Clin Endocrinol Metab 2020;105:dgaa511. [PMID: 32785703 DOI: 10.1210/clinem/dgaa511] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 108 |
Liu J, Xu F, Nie Z, Shao L. Gut Microbiota Approach-A New Strategy to Treat Parkinson's Disease. Front Cell Infect Microbiol 2020;10:570658. [PMID: 33194809 DOI: 10.3389/fcimb.2020.570658] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 109 |
Zhgun ES, Kislun YV, Kalachniuk TN, Veselovsky VA, Urban AS, Tikhonova PO, Pavlenko AV, Ilchenko GN, Ilina EN. Evaluation of the Levels of Metabolites in Feces of Patients with Inflammatory Bowel Diseases. Biochem Moscow Suppl Ser B 2020;14:312-319. [DOI: 10.1134/s1990750820040113] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 110 |
Ilchmann-Diounou H, Menard S. Psychological Stress, Intestinal Barrier Dysfunctions, and Autoimmune Disorders: An Overview. Front Immunol 2020;11:1823. [PMID: 32983091 DOI: 10.3389/fimmu.2020.01823] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 111 |
Tabeeva G, Dumanovskaya M, Asaturova A, Bogdanova I, Sanaya S, Tregubova A. Features of regulation and function of inflammasomes in inflammatory diseases of the female reproductive system. Clin Exp Morphology 2020;9:12-20. [DOI: 10.31088/cem2020.9.3.12-20] [Reference Citation Analysis]
|
| 112 |
Segal JP, Mullish BH, Quraishi MN, Iqbal T, Marchesi JR, Sokol H. Mechanisms underpinning the efficacy of faecal microbiota transplantation in treating gastrointestinal disease. Therap Adv Gastroenterol 2020;13:1756284820946904. [PMID: 32952613 DOI: 10.1177/1756284820946904] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 113 |
He Y, Xu R, Wang W, Zhang J, Hu X. Probiotics, prebiotics, antibiotic, Chinese herbal medicine, and fecal microbiota transplantation in irritable bowel syndrome: Protocol for a systematic review and network meta-analysis. Medicine (Baltimore) 2020;99:e21502. [PMID: 32769886 DOI: 10.1097/MD.0000000000021502] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 114 |
Ronai I, Greslehner GP, Boem F, Carlisle J, Stencel A, Suárez J, Bayir S, Bretting W, Formosinho J, Guerrero AC, Morgan WH, Prigot-Maurice C, Rodeck S, Vasse M, Wallis JM, Zacks O. "Microbiota, symbiosis and individuality summer school" meeting report. Microbiome 2020;8:117. [PMID: 32795355 DOI: 10.1186/s40168-020-00898-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 115 |
Li S, Mao Y, Zhou F, Yang H, Shi Q, Meng B. Gut microbiome and osteoporosis: a review. Bone Joint Res 2020;9:524-30. [PMID: 32922760 DOI: 10.1302/2046-3758.98.BJR-2020-0089.R1] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 8.7] [Reference Citation Analysis]
|
| 116 |
Ianiro G, Segal JP, Mullish BH, Quraishi MN, Porcari S, Fabiani G, Gasbarrini A, Cammarota G. Fecal microbiota transplantation in gastrointestinal and extraintestinal disorders. Future Microbiol 2020;15:1173-83. [PMID: 32954843 DOI: 10.2217/fmb-2020-0061] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 117 |
Di Costanzo M, Carucci L, Berni Canani R, Biasucci G. Gut Microbiome Modulation for Preventing and Treating Pediatric Food Allergies. Int J Mol Sci 2020;21:E5275. [PMID: 32722378 DOI: 10.3390/ijms21155275] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 118 |
Patterson TT, Nicholson S, Wallace D, Hawryluk GWJ, Grandhi R. Complex Feed-Forward and Feedback Mechanisms Underlie the Relationship Between Traumatic Brain Injury and the Gut-Microbiota-Brain Axis. Shock 2019;52:318-25. [PMID: 30335675 DOI: 10.1097/SHK.0000000000001278] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 119 |
Chadchan SB, Cheng M, Parnell LA, Yin Y, Schriefer A, Mysorekar IU, Kommagani R. Antibiotic therapy with metronidazole reduces endometriosis disease progression in mice: a potential role for gut microbiota. Hum Reprod 2019;34:1106-16. [PMID: 31037294 DOI: 10.1093/humrep/dez041] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 16.0] [Reference Citation Analysis]
|
| 120 |
Xiao Y, Angulo MT, Lao S, Weiss ST, Liu YY. An ecological framework to understand the efficacy of fecal microbiota transplantation. Nat Commun 2020;11:3329. [PMID: 32620839 DOI: 10.1038/s41467-020-17180-x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 11.7] [Reference Citation Analysis]
|
| 121 |
Jiang S, Wang B, Sha T, Li X. Changes in the Intestinal Microbiota in Patients with Stage 5 Chronic Kidney Disease on a Low-Protein Diet and the Effects of Human to Rat Fecal Microbiota Transplantation. Med Sci Monit 2020;26:e921557. [PMID: 32592577 DOI: 10.12659/MSM.921557] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 122 |
Qualls-Creekmore E, Marlatt KL, Aarts E, Bruce-Keller A, Church TS, Clément K, Fisher JO, Gordon-Larsen P, Morrison CD, Raybould HE, Ryan DH, Schauer PR, Spector AC, Spetter MS, Stuber GD, Berthoud HR, Ravussin E. What Should I Eat and Why? The Environmental, Genetic, and Behavioral Determinants of Food Choice: Summary from a Pennington Scientific Symposium. Obesity (Silver Spring) 2020;28:1386-96. [PMID: 32520444 DOI: 10.1002/oby.22806] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 123 |
Fujimoto K, Uematsu S. Vaccine therapy for dysbiosis-related diseases. World J Gastroenterol 2020; 26(21): 2758-2767 [PMID: 32550752 DOI: 10.3748/wjg.v26.i21.2758] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 124 |
Tilocca B, Pieroni L, Soggiu A, Britti D, Bonizzi L, Roncada P, Greco V. Gut-Brain Axis and Neurodegeneration: State-of-the-Art of Meta-Omics Sciences for Microbiota Characterization. Int J Mol Sci 2020;21:E4045. [PMID: 32516966 DOI: 10.3390/ijms21114045] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 11.7] [Reference Citation Analysis]
|
| 125 |
Rodriguez R, Durán P. Natural Holobiome Engineering by Using Native Extreme Microbiome to Counteract the Climate Change Effects. Front Bioeng Biotechnol 2020;8:568. [PMID: 32582678 DOI: 10.3389/fbioe.2020.00568] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 126 |
Chen YM, Liao CC, Huang YC, Chen MY, Huang CC, Chen WC, Chiu YS. Proteome and microbiota analysis highlight Lactobacillus plantarum TWK10 supplementation improves energy metabolism and exercise performance in mice. Food Sci Nutr 2020;8:3525-34. [PMID: 32724615 DOI: 10.1002/fsn3.1635] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 127 |
Okahara K, Ishikawa D, Nomura K, Ito S, Haga K, Takahashi M, Shibuya T, Osada T, Nagahara A. Matching between Donors and Ulcerative Colitis Patients Is Important for Long-Term Maintenance after Fecal Microbiota Transplantation. J Clin Med 2020;9:E1650. [PMID: 32486476 DOI: 10.3390/jcm9061650] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 128 |
Vernocchi P, Del Chierico F, Putignani L. Gut Microbiota Metabolism and Interaction with Food Components. Int J Mol Sci 2020;21:E3688. [PMID: 32456257 DOI: 10.3390/ijms21103688] [Cited by in Crossref: 30] [Cited by in F6Publishing: 37] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 129 |
Liu T, Xiao Y, Yin J, Yi T, Zhou Z, Hsiang T, Tang Q, Chen W. Effects of Cultured Root and Soil Microbial Communities on the Disease of Nicotiana tabacum Caused by Phytophthora nicotianae. Front Microbiol 2020;11:929. [PMID: 32499770 DOI: 10.3389/fmicb.2020.00929] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 130 |
Meng Y, Michelena TM, Cai F, Lou X, Li S, Zhang R. Traditional Chinese Medicine in Emergency Treatment Mechanism and Application. Open Access Emerg Med 2020;12:111-9. [PMID: 32431555 DOI: 10.2147/OAEM.S244110] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 131 |
Korach-Rechtman H, Hreish M, Fried C, Gerassy-Vainberg S, Azzam ZS, Kashi Y, Berger G. Intestinal Dysbiosis in Carriers of Carbapenem-Resistant Enterobacteriaceae. mSphere 2020;5:e00173-20. [PMID: 32350099 DOI: 10.1128/mSphere.00173-20] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 132 |
Nowland TL, Torok VA, Low WY, Barton MD, Plush KJ, Kirkwood RN. Faecal Microbiota Analysis of Piglets During Lactation. Animals (Basel) 2020;10:E762. [PMID: 32349423 DOI: 10.3390/ani10050762] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 133 |
Novakovic M, Rout A, Kingsley T, Kirchoff R, Singh A, Verma V, Kant R, Chaudhary R. Role of gut microbiota in cardiovascular diseases. World J Cardiol 2020; 12(4): 110-122 [PMID: 32431782 DOI: 10.4330/wjc.v12.i4.110] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 19.0] [Reference Citation Analysis]
|
| 134 |
Jin L, Wu D, Li C, Zhang A, Xiong Y, Wei R, Zhang G, Yang S, Deng W, Li T, Li B, Pan X, Zhang Z, Huang Y, Zhang H, He Y, Zou L. Bamboo nutrients and microbiome affect gut microbiome of giant panda. Symbiosis 2020;80:293-304. [DOI: 10.1007/s13199-020-00673-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 135 |
Sun S, Wang F. Molecular Events Behind Adverse Effects. Adv Exp Med Biol 2020;1248:119-41. [PMID: 32185709 DOI: 10.1007/978-981-15-3266-5_6] [Reference Citation Analysis]
|
| 136 |
Teng T, Gao F, He W, Fu H, Guo J, Bai G, Shi B. An Early Fecal Microbiota Transfer Improves the Intestinal Conditions on Microflora and Immunoglobulin and Antimicrobial Peptides in Piglets. J Agric Food Chem 2020;68:4830-43. [PMID: 32252520 DOI: 10.1021/acs.jafc.0c00545] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 137 |
Baral B, Mozafari MR. Strategic Moves of "Superbugs" Against Available Chemical Scaffolds: Signaling, Regulation, and Challenges. ACS Pharmacol Transl Sci 2020;3:373-400. [PMID: 32566906 DOI: 10.1021/acsptsci.0c00005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 138 |
Dovrolis N, Kolios G, Spyrou GM, Maroulakou I. Computational profiling of the gut-brain axis: microflora dysbiosis insights to neurological disorders. Brief Bioinform 2019;20:825-41. [PMID: 29186317 DOI: 10.1093/bib/bbx154] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 139 |
Lee KH, Song Y, Wu W, Yu K, Zhang G. The gut microbiota, environmental factors, and links to the development of food allergy. Clin Mol Allergy 2020;18:5. [PMID: 32265597 DOI: 10.1186/s12948-020-00120-x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 11.3] [Reference Citation Analysis]
|
| 140 |
Selvig D, Piceno Y, Terdiman J, Zydek M, Umetsu SE, Balitzer D, Fadrosh D, Lynch K, Lamere B, Leith T, Kassam Z, Beck K, Lewin S, Ma A, Somsouk M, Lynch SV, El-Nachef N. Fecal Microbiota Transplantation in Pouchitis: Clinical, Endoscopic, Histologic, and Microbiota Results from a Pilot Study. Dig Dis Sci 2020;65:1099-106. [PMID: 31302808 DOI: 10.1007/s10620-019-05715-2] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 141 |
Jin CY, Hu Y, Jin B. Faecal microbiota transplantation: Application in treatment of some digestive diseases and safety concerns. Shijie Huaren Xiaohua Zazhi 2020; 28(4): 135-143 [DOI: 10.11569/wcjd.v28.i4.135] [Reference Citation Analysis]
|
| 142 |
Chen K, Fu Y, Wang Y, Liao L, Xu H, Zhang A, Zhang J, Fan L, Ren J, Fang B. Therapeutic Effects of the In Vitro Cultured Human Gut Microbiota as Transplants on Altering Gut Microbiota and Improving Symptoms Associated with Autism Spectrum Disorder. Microb Ecol 2020;80:475-86. [DOI: 10.1007/s00248-020-01494-w] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 143 |
Venkataraman B, Ojha S, Belur PD, Bhongade B, Raj V, Collin PD, Adrian TE, Subramanya SB. Phytochemical drug candidates for the modulation of peroxisome proliferator-activated receptor γ in inflammatory bowel diseases. Phytother Res 2020;34:1530-49. [PMID: 32009281 DOI: 10.1002/ptr.6625] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 144 |
Aditya A, Galleher C, Ad Y, Coburn M, Zweig A. Gut Microbiome in Inflammation and Chronic Enteric Infections. Gut Microbiome and Its Impact on Health and Diseases 2020. [DOI: 10.1007/978-3-030-47384-6_6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 145 |
Zwiernik B, Arłukowicz T, Mycko M, Zwiernik J. Gut microbiota modification as an option in multiple sclerosis management. Pol Ann Med 2020. [DOI: 10.29089/2020.20.00133] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 146 |
Salas Garcia MC, Schorr AR, Arnold W, Fei N, Gilbert JA. Pets as a Novel Microbiome-Based Therapy. Pets as Sentinels, Forecasters and Promoters of Human Health 2020. [DOI: 10.1007/978-3-030-30734-9_11] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 147 |
Chowdhury G, Ramamurthy T. Influence of Antimicrobials on the Gut Microbiota. Antimicrobial Resistance 2020. [DOI: 10.1007/978-981-15-3658-8_3] [Reference Citation Analysis]
|
| 148 |
Heimesaat MM, Mrazek K, Bereswill S. Murine fecal microbiota transplantation lowers gastrointestinal pathogen loads and dampens pro-inflammatory immune responses in Campylobacter jejuni infected secondary abiotic mice. Sci Rep 2019;9:19797. [PMID: 31875037 DOI: 10.1038/s41598-019-56442-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 149 |
Costello SP, Bryant RV. Faecal microbiota transplantation in Australia: bogged down in regulatory uncertainty. Intern Med J 2019;49:148-51. [PMID: 30754077 DOI: 10.1111/imj.14212] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 150 |
Li X, Chu Q, Huang Y, Xiao Y, Song L, Zhu S, Kang Y, Lu S, Xu J, Ren Z. Consortium of Probiotics Attenuates Colonization of Clostridioides difficile. Front Microbiol 2019;10:2871. [PMID: 31921049 DOI: 10.3389/fmicb.2019.02871] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 151 |
Niina A, Kibe R, Suzuki R, Yuchi Y, Teshima T, Matsumoto H, Kataoka Y, Koyama H. Improvement in Clinical Symptoms and Fecal Microbiome After Fecal Microbiota Transplantation in a Dog with Inflammatory Bowel Disease. Vet Med (Auckl) 2019;10:197-201. [PMID: 31819862 DOI: 10.2147/VMRR.S230862] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 152 |
Xi D, Michail S. Fecal microbiota transplantation in children does not significantly alter body mass index. Transl Pediatr 2019;8:398-401. [PMID: 31993353 DOI: 10.21037/tp.2019.09.05] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 153 |
Leung PC, Cheng KF. Fecal microbiota transplantation: Historical review and current perspective. World J Meta-Anal 2019; 7(9): 423-427 [DOI: 10.13105/wjma.v7.i9.423] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 154 |
Mileto S, Das A, Lyras D. Enterotoxic Clostridia:Clostridioides difficileInfections. Gram-Positive Pathogens 2019. [DOI: 10.1128/9781683670131.ch61] [Reference Citation Analysis]
|
| 155 |
Korach-rechtman H, Hreish M, Fried C, Gerassy-vainberg S, Azzam ZS, Kashi Y, Berger G. Intestinal dysbiosis in carbapenem-resistant Enterobacteriaceae carriers.. [DOI: 10.1101/855718] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 156 |
Kumar V, Fischer M. Expert opinion on fecal microbiota transplantation for the treatment of Clostridioides difficile infection and beyond. Expert Opin Biol Ther. 2020;20:73-81. [PMID: 31690143 DOI: 10.1080/14712598.2020.1689952] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 157 |
Wang Z, Hua W, Li C, Chang H, Liu R, Ni Y, Sun H, Li Y, Wang X, Hou M, Liu Y, Xu Z, Ji M. Protective Role of Fecal Microbiota Transplantation on Colitis and Colitis-Associated Colon Cancer in Mice Is Associated With Treg Cells. Front Microbiol 2019;10:2498. [PMID: 31798539 DOI: 10.3389/fmicb.2019.02498] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 158 |
Dean AD, Horsburgh MJ, Vasiev B. Toxin-mediated competition in weakly motile bacteria. J Theor Biol 2019;480:205-17. [PMID: 31348925 DOI: 10.1016/j.jtbi.2019.07.013] [Reference Citation Analysis]
|
| 159 |
Rajakovich LJ, Balskus EP. Metabolic functions of the human gut microbiota: the role of metalloenzymes. Nat Prod Rep 2019;36:593-625. [PMID: 30452039 DOI: 10.1039/c8np00074c] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 160 |
Yang D, Zhao D, Ali Shah SZ, Wu W, Lai M, Zhang X, Li J, Guan Z, Zhao H, Li W, Gao H, Zhou X, Yang L. The Role of the Gut Microbiota in the Pathogenesis of Parkinson's Disease. Front Neurol 2019;10:1155. [PMID: 31781020 DOI: 10.3389/fneur.2019.01155] [Cited by in Crossref: 61] [Cited by in F6Publishing: 64] [Article Influence: 15.3] [Reference Citation Analysis]
|
| 161 |
Hocquart M, Pham T, Kuete E, Tomei E, Lagier JC, Raoult D. Successful Fecal Microbiota Transplantation in a Patient Suffering From Irritable Bowel Syndrome and Recurrent Urinary Tract Infections. Open Forum Infect Dis 2019;6:ofz398. [PMID: 31660360 DOI: 10.1093/ofid/ofz398] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 162 |
Faivre B, Bellenger J, Rieu A, Guivier E, Galan M, Ollivier A, Poloni L, Sorci G. Disentangling the effect of host genetics and gut microbiota on resistance to an intestinal parasite. International Journal for Parasitology 2019;49:873-83. [DOI: 10.1016/j.ijpara.2019.06.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 163 |
Verma R, Lee C, Jeun EJ, Yi J, Kim KS, Ghosh A, Byun S, Lee CG, Kang HJ, Kim GC, Jun CD, Jan G, Suh CH, Jung JY, Sprent J, Rudra D, De Castro C, Molinaro A, Surh CD, Im SH. Cell surface polysaccharides of Bifidobacterium bifidum induce the generation of Foxp3+ regulatory T cells. Sci Immunol 2018;3:eaat6975. [PMID: 30341145 DOI: 10.1126/sciimmunol.aat6975] [Cited by in Crossref: 91] [Cited by in F6Publishing: 99] [Article Influence: 22.8] [Reference Citation Analysis]
|
| 164 |
Zhang Z, Mocanu V, Cai C, Dang J, Slater L, Deehan EC, Walter J, Madsen KL. Impact of Fecal Microbiota Transplantation on Obesity and Metabolic Syndrome-A Systematic Review.Nutrients. 2019;11. [PMID: 31557953 DOI: 10.3390/nu11102291] [Cited by in Crossref: 90] [Cited by in F6Publishing: 93] [Article Influence: 22.5] [Reference Citation Analysis]
|
| 165 |
Mandrioli J, Amedei A, Cammarota G, Niccolai E, Zucchi E, D'Amico R, Ricci F, Quaranta G, Spanu T, Masucci L. FETR-ALS Study Protocol: A Randomized Clinical Trial of Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis. Front Neurol 2019;10:1021. [PMID: 31620079 DOI: 10.3389/fneur.2019.01021] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 166 |
Lavazza A, Sironi VA. Are we Ready for a "Microbiome-Guided Behaviour" Approach? Camb Q Healthc Ethics 2019;28:708-24. [PMID: 31526431 DOI: 10.1017/S0963180119000653] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 167 |
Branca JJV, Gulisano M, Nicoletti C. Intestinal epithelial barrier functions in ageing. Ageing Res Rev 2019;54:100938. [PMID: 31369869 DOI: 10.1016/j.arr.2019.100938] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 10.3] [Reference Citation Analysis]
|
| 168 |
Igudesman D, Sweeney M, Carroll IM, Mayer-Davis EJ, Bulik CM. Gut-Brain Interactions: Implications for a Role of the Gut Microbiota in the Treatment and Prognosis of Anorexia Nervosa and Comparison to Type I Diabetes. Gastroenterol Clin North Am 2019;48:343-56. [PMID: 31383275 DOI: 10.1016/j.gtc.2019.04.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 169 |
Zhou Y, Xu H, Huang H, Li Y, Chen H, He J, Du Y, Chen Y, Zhou Y, Nie Y. Are There Potential Applications of Fecal Microbiota Transplantation beyond Intestinal Disorders? Biomed Res Int. 2019;2019:3469754. [PMID: 31467881 DOI: 10.1155/2019/3469754] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 170 |
Hu J, Ma L, Nie Y, Chen J, Zheng W, Wang X, Xie C, Zheng Z, Wang Z, Yang T, Shi M, Chen L, Hou Q, Niu Y, Xu X, Zhu Y, Zhang Y, Wei H, Yan X. A Microbiota-Derived Bacteriocin Targets the Host to Confer Diarrhea Resistance in Early-Weaned Piglets. Cell Host Microbe 2018;24:817-832.e8. [PMID: 30543777 DOI: 10.1016/j.chom.2018.11.006] [Cited by in Crossref: 92] [Cited by in F6Publishing: 97] [Article Influence: 23.0] [Reference Citation Analysis]
|
| 171 |
Rincel M, Darnaudéry M. Maternal separation in rodents: a journey from gut to brain and nutritional perspectives. Proc Nutr Soc 2020;79:113-32. [PMID: 31250784 DOI: 10.1017/S0029665119000958] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 172 |
Kehe J, Kulesa A, Ortiz A, Ackerman CM, Thakku SG, Sellers D, Kuehn S, Gore J, Friedman J, Blainey PC. Massively parallel screening of synthetic microbial communities. Proc Natl Acad Sci U S A 2019;116:12804-9. [PMID: 31186361 DOI: 10.1073/pnas.1900102116] [Cited by in Crossref: 119] [Cited by in F6Publishing: 126] [Article Influence: 29.8] [Reference Citation Analysis]
|
| 173 |
Mileto S, Das A, Lyras D, Fischetti VA, Novick RP, Ferretti JJ, Portnoy DA, Rood JI. Enterotoxic Clostridia: Clostridioides difficile Infections. Microbiol Spectr 2019;7. [DOI: 10.1128/microbiolspec.gpp3-0015-2018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 174 |
Introduction to prokaryotic metabolism and physiology. Prokaryotic Metabolism and Physiology 2019. [DOI: 10.1017/9781316761625.001] [Reference Citation Analysis]
|
| 175 |
Noce A, Marrone G, Di Daniele F, Ottaviani E, Wilson Jones G, Bernini R, Romani A, Rovella V. Impact of Gut Microbiota Composition on Onset and Progression of Chronic Non-Communicable Diseases. Nutrients 2019;11:E1073. [PMID: 31091761 DOI: 10.3390/nu11051073] [Cited by in Crossref: 61] [Cited by in F6Publishing: 64] [Article Influence: 15.3] [Reference Citation Analysis]
|
| 176 |
Jones EW, Carlson JM. Steady-state reduction of generalized Lotka-Volterra systems in the microbiome. Phys Rev E 2019;99:032403. [PMID: 30999462 DOI: 10.1103/PhysRevE.99.032403] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 177 |
Czepiel J, Dróżdż M, Pituch H, Kuijper EJ, Perucki W, Mielimonka A, Goldman S, Wultańska D, Garlicki A, Biesiada G. Clostridium difficile infection: review. Eur J Clin Microbiol Infect Dis 2019;38:1211-21. [PMID: 30945014 DOI: 10.1007/s10096-019-03539-6] [Cited by in Crossref: 184] [Cited by in F6Publishing: 154] [Article Influence: 46.0] [Reference Citation Analysis]
|
| 178 |
Wang W, Lin L, Du Y, Song Y, Peng X, Chen X, Yang CJ. Assessing the viability of transplanted gut microbiota by sequential tagging with D-amino acid-based metabolic probes. Nat Commun. 2019;10:1317. [PMID: 30899006 DOI: 10.1038/s41467-019-09267-x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 11.3] [Reference Citation Analysis]
|
| 179 |
Helmink BA, Khan MAW, Hermann A, Gopalakrishnan V, Wargo JA. The microbiome, cancer, and cancer therapy. Nat Med 2019;25:377-88. [DOI: 10.1038/s41591-019-0377-7] [Cited by in Crossref: 444] [Cited by in F6Publishing: 459] [Article Influence: 111.0] [Reference Citation Analysis]
|
| 180 |
Kang Y, Cai Y. Altered Gut Microbiota in HIV Infection: Future Perspective of Fecal Microbiota Transplantation Therapy. AIDS Res Hum Retroviruses 2019;35:229-35. [PMID: 29877092 DOI: 10.1089/AID.2017.0268] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 181 |
Nowland TL, Plush KJ, Barton M, Kirkwood RN. Development and Function of the Intestinal Microbiome and Potential Implications for Pig Production. Animals (Basel) 2019;9:E76. [PMID: 30823381 DOI: 10.3390/ani9030076] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 10.5] [Reference Citation Analysis]
|
| 182 |
Lam TJ, Ye Y. CRISPRs for Strain Tracking and Their Application to Microbiota Transplantation Data Analysis. CRISPR J 2019;2:41-50. [PMID: 30820491 DOI: 10.1089/crispr.2018.0046] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 183 |
Yeruva T, Lee CH. Regulation of Vaginal Microbiome by Nitric Oxide. Curr Pharm Biotechnol 2019;20:17-31. [PMID: 30727888 DOI: 10.2174/1389201020666190207092850] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 184 |
Lai CY, Sung J, Cheng F, Tang W, Wong SH, Chan PKS, Kamm MA, Sung JJY, Kaplan G, Chan FKL, Ng SC. Systematic review with meta-analysis: review of donor features, procedures and outcomes in 168 clinical studies of faecal microbiota transplantation. Aliment Pharmacol Ther 2019;49:354-63. [PMID: 30628108 DOI: 10.1111/apt.15116] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 14.3] [Reference Citation Analysis]
|
| 185 |
Li X, Song L, Zhu S, Xiao Y, Huang Y, Hua Y, Chu Q, Ren Z. Two Strains of Lactobacilli Effectively Decrease the Colonization of VRE in a Mouse Model. Front Cell Infect Microbiol 2019;9:6. [PMID: 30761273 DOI: 10.3389/fcimb.2019.00006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 186 |
Hasan AU, Rahman A, Kobori H. Interactions between Host PPARs and Gut Microbiota in Health and Disease. Int J Mol Sci 2019;20:E387. [PMID: 30658440 DOI: 10.3390/ijms20020387] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 187 |
Yuan M, Li D, Zhang Z, Sun H, An M, Wang G. Endometriosis induces gut microbiota alterations in mice. Hum Reprod 2018;33:607-16. [PMID: 29462324 DOI: 10.1093/humrep/dex372] [Cited by in Crossref: 55] [Cited by in F6Publishing: 58] [Article Influence: 13.8] [Reference Citation Analysis]
|
| 188 |
Sugita K, Yanuma N, Ohno H, Takahashi K, Kawano K, Morita H, Ohmori K. Oral faecal microbiota transplantation for the treatment of Clostridium difficile-associated diarrhoea in a dog: a case report. BMC Vet Res 2019;15:11. [PMID: 30616615 DOI: 10.1186/s12917-018-1754-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 189 |
Takahashi M, Ishikawa D, Sasaki T, Lu YJ, Kuwahara-Arai K, Kamei M, Shibuya T, Osada T, Hiramatsu K, Nagahara A. Faecal freezing preservation period influences colonization ability for faecal microbiota transplantation. J Appl Microbiol 2019;126:973-84. [PMID: 30489686 DOI: 10.1111/jam.14167] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 190 |
Brennan L, Al KF, Bjazevic J, Razvi H, Burton JP. The Use of Probiotics and Other Microbiota Therapies to Mitigate Recurrent Calcium Oxalate Stone Formation. The Role of Bacteria in Urology 2019. [DOI: 10.1007/978-3-030-17542-9_8] [Reference Citation Analysis]
|
| 191 |
Dam B, Misra A, Banerjee S. Role of Gut Microbiota in Combating Oxidative Stress. Oxidative Stress in Microbial Diseases 2019. [DOI: 10.1007/978-981-13-8763-0_4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 192 |
Vaughn BP, Rank KM, Khoruts A. Fecal Microbiota Transplantation: Current Status in Treatment of GI and Liver Disease. Clin Gastroenterol Hepatol 2019;17:353-61. [PMID: 30055267 DOI: 10.1016/j.cgh.2018.07.026] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 9.8] [Reference Citation Analysis]
|
| 193 |
Borody T. Fecal Microbiota Transplantation. Gastrointestinal Diseases and their Associated Infections 2019. [DOI: 10.1016/b978-0-323-54843-4.00018-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 194 |
Hu J, Ma L, Zheng W, Nie Y, Yan X. Lactobacillus gasseri LA39 Activates the Oxidative Phosphorylation Pathway in Porcine Intestinal Epithelial Cells. Front Microbiol 2018;9:3025. [PMID: 30619122 DOI: 10.3389/fmicb.2018.03025] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 195 |
Wang Y, Wiesnoski DH, Helmink BA, Gopalakrishnan V, Choi K, DuPont HL, Jiang ZD, Abu-Sbeih H, Sanchez CA, Chang CC, Parra ER, Francisco-Cruz A, Raju GS, Stroehlein JR, Campbell MT, Gao J, Subudhi SK, Maru DM, Blando JM, Lazar AJ, Allison JP, Sharma P, Tetzlaff MT, Wargo JA, Jenq RR. Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis. Nat Med. 2018;24:1804-1808. [PMID: 30420754 DOI: 10.1038/s41591-018-0238-9] [Cited by in Crossref: 321] [Cited by in F6Publishing: 352] [Article Influence: 64.2] [Reference Citation Analysis]
|
| 196 |
McDonald JAK, Mullish BH, Pechlivanis A, Liu Z, Brignardello J, Kao D, Holmes E, Li JV, Clarke TB, Thursz MR, Marchesi JR. Inhibiting Growth of Clostridioides difficile by Restoring Valerate, Produced by the Intestinal Microbiota. Gastroenterology 2018;155:1495-1507.e15. [PMID: 30025704 DOI: 10.1053/j.gastro.2018.07.014] [Cited by in Crossref: 97] [Cited by in F6Publishing: 96] [Article Influence: 19.4] [Reference Citation Analysis]
|
| 197 |
Fang H, Fu L, Wang J. Protocol for Fecal Microbiota Transplantation in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Biomed Res Int. 2018;2018:8941340. [PMID: 30302341 DOI: 10.1155/2018/8941340] [Cited by in Crossref: 43] [Cited by in F6Publishing: 53] [Article Influence: 8.6] [Reference Citation Analysis]
|
| 198 |
Ding C, Tang W, Fan X, Wu G. Intestinal microbiota: a novel perspective in colorectal cancer biotherapeutics. Onco Targets Ther 2018;11:4797-810. [PMID: 30147331 DOI: 10.2147/OTT.S170626] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 199 |
Bastiaanssen TFS, Cowan CSM, Claesson MJ, Dinan TG, Cryan JF. Making Sense of … the Microbiome in Psychiatry. Int J Neuropsychopharmacol 2019;22:37-52. [PMID: 30099552 DOI: 10.1093/ijnp/pyy067] [Cited by in Crossref: 102] [Cited by in F6Publishing: 99] [Article Influence: 20.4] [Reference Citation Analysis]
|
| 200 |
Vargason AM, Anselmo AC. Clinical translation of microbe-based therapies: Current clinical landscape and preclinical outlook. Bioeng Transl Med 2018;3:124-37. [PMID: 30065967 DOI: 10.1002/btm2.10093] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 6.2] [Reference Citation Analysis]
|
| 201 |
Daliri EB, Tango CN, Lee BH, Oh D. Human microbiome restoration and safety. International Journal of Medical Microbiology 2018;308:487-97. [DOI: 10.1016/j.ijmm.2018.05.002] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 202 |
Zhu CS, Grandhi R, Patterson TT, Nicholson SE. A Review of Traumatic Brain Injury and the Gut Microbiome: Insights into Novel Mechanisms of Secondary Brain Injury and Promising Targets for Neuroprotection. Brain Sci 2018;8:E113. [PMID: 29921825 DOI: 10.3390/brainsci8060113] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 9.8] [Reference Citation Analysis]
|
| 203 |
Hu J, Chen L, Tang Y, Xie C, Xu B, Shi M, Zheng W, Zhou S, Wang X, Liu L, Yan Y, Yang T, Niu Y, Hou Q, Xu X, Yan X. Standardized Preparation for Fecal Microbiota Transplantation in Pigs. Front Microbiol 2018;9:1328. [PMID: 29971061 DOI: 10.3389/fmicb.2018.01328] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 204 |
Bhutiani N, Schucht JE, Miller KR, McClave SA. Technical Aspects of Fecal Microbial Transplantation (FMT). Curr Gastroenterol Rep 2018;20:30. [PMID: 29886561 DOI: 10.1007/s11894-018-0636-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 205 |
D'Odorico I, Di Bella S, Monticelli J, Giacobbe DR, Boldock E, Luzzati R. Role of fecal microbiota transplantation in inflammatory bowel disease. J Dig Dis 2018;19:322-34. [PMID: 29696802 DOI: 10.1111/1751-2980.12603] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 206 |
Rizzetto L, Fava F, Tuohy KM, Selmi C. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex. J Autoimmun 2018;92:12-34. [PMID: 29861127 DOI: 10.1016/j.jaut.2018.05.008] [Cited by in Crossref: 141] [Cited by in F6Publishing: 150] [Article Influence: 28.2] [Reference Citation Analysis]
|
| 207 |
Jeon SR, Chai J, Kim C, Lee CH. Current Evidence for the Management of Inflammatory Bowel Diseases Using Fecal Microbiota Transplantation. Curr Infect Dis Rep 2018;20:21. [PMID: 29804272 DOI: 10.1007/s11908-018-0627-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 208 |
Kutsuna R, Tomida J, Morita Y, Kawamura Y. Paraclostridium bifermentans exacerbates pathosis in a mouse model of ulcerative colitis. PLoS One 2018;13:e0197668. [PMID: 29782507 DOI: 10.1371/journal.pone.0197668] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 209 |
El-Salhy M, Mazzawi T. Fecal microbiota transplantation for managing irritable bowel syndrome. Expert Rev Gastroenterol Hepatol 2018;12:439-45. [PMID: 29493330 DOI: 10.1080/17474124.2018.1447380] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 8.2] [Reference Citation Analysis]
|
| 210 |
Guo YF, Shu L, Tan ZJ. Role of intestinal Clostridium in pathogenesis and treatment of diarrhea. Shijie Huaren Xiaohua Zazhi 2018; 26(12): 693-699 [DOI: 10.11569/wcjd.v26.i12.693] [Reference Citation Analysis]
|
| 211 |
O’malley MA, Skillings DJ. Methodological Strategies in Microbiome Research and their Explanatory Implications. Perspectives on Science 2018;26:239-65. [DOI: 10.1162/posc_a_00274] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 212 |
Bibliography. The New Microbiology 2018. [DOI: 10.1128/9781683670117.biblio] [Reference Citation Analysis]
|
| 213 |
Yoon MY, Yoon SS. Disruption of the Gut Ecosystem by Antibiotics. Yonsei Med J 2018;59:4-12. [PMID: 29214770 DOI: 10.3349/ymj.2018.59.1.4] [Cited by in Crossref: 86] [Cited by in F6Publishing: 90] [Article Influence: 17.2] [Reference Citation Analysis]
|
| 214 |
Zhu D, Sorg JA, Sun X. Clostridioides difficile Biology: Sporulation, Germination, and Corresponding Therapies for C. difficile Infection. Front Cell Infect Microbiol 2018;8:29. [PMID: 29473021 DOI: 10.3389/fcimb.2018.00029] [Cited by in Crossref: 59] [Cited by in F6Publishing: 67] [Article Influence: 11.8] [Reference Citation Analysis]
|
| 215 |
Kaplan I, Pineda A, Bezemer M. Application and Theory of Plant–Soil Feedbacks on Aboveground Herbivores. Aboveground–Belowground Community Ecology 2018. [DOI: 10.1007/978-3-319-91614-9_14] [Cited by in Crossref: 14] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 216 |
Tungland B. Intestinal Dysbiosis in Obesity, Metabolic Syndrome and Related Metabolic Diseases: Therapeutic Strategies Utilizing Dietary Modification, Pro- and Prebiotics, and Fecal Microbial Transplant (FMT) Therapy. Human Microbiota in Health and Disease 2018. [DOI: 10.1016/b978-0-12-814649-1.00011-9] [Reference Citation Analysis]
|
| 217 |
Tungland B. Dysbiosis of the Microbiota: Therapeutic Strategies Utilizing Dietary Modification, Pro- and Prebiotics and Fecal Transplant Therapies in Promoting Normal Balance and Local GI Functions. Human Microbiota in Health and Disease 2018. [DOI: 10.1016/b978-0-12-814649-1.00009-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 218 |
Ma Y, Chen H, Lei R, Ren J. Biobanking for human microbiome research: promise, risks, and ethics. ABR 2017;9:311-24. [DOI: 10.1007/s41649-017-0033-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 219 |
Zamudio-tiburcio Á, Bermúdez-ruiz H, Lezama-guzmán HR, Guevara-ortigoza MDP, Islas-solares E, Sosa-lópez FA. Rompiendo paradigmas. Trasplante de microbiota intestinal: reporte preliminar. Cirugía y Cirujanos 2017;85:6-12. [DOI: 10.1016/j.circir.2016.11.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 220 |
Qin C, Zhang H, Zhao L, Zeng M, Huang W, Fu G, Zhou W, Wang H, Yan H. Microbiota transplantation reveals beneficial impact of berberine on hepatotoxicity by improving gut homeostasis. Sci China Life Sci 2018;61:1537-44. [DOI: 10.1007/s11427-017-9202-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 221 |
Mesa D, Lammel DR, Balsanelli E, Sena C, Noseda MD, Caron LF, Cruz LM, Pedrosa FO, Souza EM. Cecal Microbiota in Broilers Fed with Prebiotics. Front Genet 2017;8:153. [PMID: 29089963 DOI: 10.3389/fgene.2017.00153] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 222 |
Paramsothy S, Paramsothy R, Rubin DT, Kamm MA, Kaakoush NO, Mitchell HM, Castaño-Rodríguez N. Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. J Crohns Colitis 2017;11:1180-99. [PMID: 28486648 DOI: 10.1093/ecco-jcc/jjx063] [Cited by in Crossref: 269] [Cited by in F6Publishing: 271] [Article Influence: 44.8] [Reference Citation Analysis]
|
| 223 |
Cui M, Xiao H, Li Y, Zhou L, Zhao S, Luo D, Zheng Q, Dong J, Zhao Y, Zhang X, Zhang J, Lu L, Wang H, Fan S. Faecal microbiota transplantation protects against radiation-induced toxicity. EMBO Mol Med 2017;9:448-61. [PMID: 28242755 DOI: 10.15252/emmm.201606932] [Cited by in Crossref: 130] [Cited by in F6Publishing: 140] [Article Influence: 21.7] [Reference Citation Analysis]
|
| 224 |
Silberger DJ, Zindl CL, Weaver CT. Citrobacter rodentium: a model enteropathogen for understanding the interplay of innate and adaptive components of type 3 immunity. Mucosal Immunol 2017;10:1108-17. [PMID: 28612839 DOI: 10.1038/mi.2017.47] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 225 |
Grigg JB, Sonnenberg GF. Host-Microbiota Interactions Shape Local and Systemic Inflammatory Diseases. J Immunol 2017;198:564-71. [PMID: 28069751 DOI: 10.4049/jimmunol.1601621] [Cited by in Crossref: 67] [Cited by in F6Publishing: 70] [Article Influence: 11.2] [Reference Citation Analysis]
|
| 226 |
Kang Y, Cai Y. Gut microbiota and obesity: implications for fecal microbiota transplantation therapy. Hormones 2017;16:223-34. [DOI: 10.1007/bf03401517] [Cited by in Crossref: 27] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 227 |
Damjanovic K, Blackall LL, Webster NS, van Oppen MJH. The contribution of microbial biotechnology to mitigating coral reef degradation. Microb Biotechnol 2017;10:1236-43. [PMID: 28696067 DOI: 10.1111/1751-7915.12769] [Cited by in Crossref: 69] [Cited by in F6Publishing: 69] [Article Influence: 11.5] [Reference Citation Analysis]
|
| 228 |
Bron PA, Kleerebezem M, Brummer RJ, Cani PD, Mercenier A, MacDonald TT, Garcia-Ródenas CL, Wells JM. Can probiotics modulate human disease by impacting intestinal barrier function? Br J Nutr 2017;117:93-107. [PMID: 28102115 DOI: 10.1017/S0007114516004037] [Cited by in Crossref: 240] [Cited by in F6Publishing: 244] [Article Influence: 40.0] [Reference Citation Analysis]
|
| 229 |
Suzuki K, Yoshida K, Nakanishi Y, Fukuda S, Mcmahon S. An equation‐free method reveals the ecological interaction networks within complex microbial ecosystems. Methods Ecol Evol 2017;8:1774-85. [DOI: 10.1111/2041-210x.12814] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 230 |
Ehret T, Torelli F, Klotz C, Pedersen AB, Seeber F. Translational Rodent Models for Research on Parasitic Protozoa-A Review of Confounders and Possibilities. Front Cell Infect Microbiol 2017;7:238. [PMID: 28638807 DOI: 10.3389/fcimb.2017.00238] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 231 |
Weaver KR, Melkus GD, Henderson WA. Irritable Bowel Syndrome. Am J Nurs 2017;117:48-55. [PMID: 28541989 DOI: 10.1097/01.NAJ.0000520253.57459.01] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 232 |
Kelly DL, Lyon DE, Yoon SL, Horgas AL. The Microbiome and Cancer: Implications for Oncology Nursing Science. Cancer Nurs 2016;39:E56-62. [PMID: 26110573 DOI: 10.1097/NCC.0000000000000286] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 233 |
Staley C, Hamilton MJ, Vaughn BP, Graiziger CT, Newman KM, Kabage AJ, Sadowsky MJ, Khoruts A. Successful Resolution of Recurrent Clostridium difficile Infection using Freeze-Dried, Encapsulated Fecal Microbiota; Pragmatic Cohort Study. Am J Gastroenterol 2017;112:940-7. [PMID: 28195180 DOI: 10.1038/ajg.2017.6] [Cited by in Crossref: 118] [Cited by in F6Publishing: 124] [Article Influence: 19.7] [Reference Citation Analysis]
|
| 234 |
Alexander JL, Wilson ID, Teare J, Marchesi JR, Nicholson JK, Kinross JM. Gut microbiota modulation of chemotherapy efficacy and toxicity. Nat Rev Gastroenterol Hepatol 2017;14:356-65. [PMID: 28270698 DOI: 10.1038/nrgastro.2017.20] [Cited by in Crossref: 451] [Cited by in F6Publishing: 455] [Article Influence: 75.2] [Reference Citation Analysis]
|
| 235 |
Ma Y, Yang J, Cui B, Xu H, Xiao C, Zhang F. How Chinese clinicians face ethical and social challenges in fecal microbiota transplantation: a questionnaire study. BMC Med Ethics. 2017;18:39. [PMID: 28569156 DOI: 10.1186/s12910-017-0200-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 236 |
He Z, Cui BT, Zhang T, Li P, Long CY, Ji GZ, Zhang FM. Fecal microbiota transplantation cured epilepsy in a case with Crohn’s disease: The first report. World J Gastroenterol 2017; 23(19): 3565-3568 [PMID: 28596693 DOI: 10.3748/wjg.v23.i19.3565] [Cited by in CrossRef: 129] [Cited by in F6Publishing: 132] [Article Influence: 21.5] [Reference Citation Analysis]
|
| 237 |
朱艳丽, 郭晓鹤, 张兰芳, 秦咏梅. 粪菌移植治疗溃疡性结肠炎1例. 世界华人消化杂志 2017; 25(14): 1321-1326 [DOI: 10.11569/wcjd.v25.i14.1321] [Reference Citation Analysis]
|
| 238 |
Haque SZ, Haque M. The ecological community of commensal, symbiotic, and pathogenic gastrointestinal microorganisms - an appraisal. Clin Exp Gastroenterol 2017;10:91-103. [PMID: 28503071 DOI: 10.2147/CEG.S126243] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 239 |
Ma Y, Liu J, Rhodes C, Nie Y, Zhang F. Ethical Issues in Fecal Microbiota Transplantation in Practice. Am J Bioeth 2017;17:34-45. [PMID: 28430065 DOI: 10.1080/15265161.2017.1299240] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 240 |
Kang Y, Cai Y. Gut microbiota and hepatitis-B-virus-induced chronic liver disease: implications for faecal microbiota transplantation therapy. J Hosp Infect 2017;96:342-8. [PMID: 28545829 DOI: 10.1016/j.jhin.2017.04.007] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 241 |
Stoltz KL, Erickson R, Staley C, Weingarden AR, Romens E, Steer CJ, Khoruts A, Sadowsky MJ, Dosa PI. Synthesis and Biological Evaluation of Bile Acid Analogues Inhibitory to Clostridium difficile Spore Germination. J Med Chem 2017;60:3451-71. [PMID: 28402634 DOI: 10.1021/acs.jmedchem.7b00295] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 242 |
Sharon G, Sampson TR, Geschwind DH, Mazmanian SK. The Central Nervous System and the Gut Microbiome. Cell. 2016;167:915-932. [PMID: 27814521 DOI: 10.1016/j.cell.2016.10.027] [Cited by in Crossref: 697] [Cited by in F6Publishing: 722] [Article Influence: 116.2] [Reference Citation Analysis]
|
| 243 |
van Beurden YH, Nieuwdorp M, van de Berg PJEJ, Mulder CJJ, Goorhuis A. Current challenges in the treatment of severe Clostridium difficile infection: early treatment potential of fecal microbiota transplantation. Therap Adv Gastroenterol 2017;10:373-81. [PMID: 28491142 DOI: 10.1177/1756283X17690480] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 244 |
Ott SJ, Waetzig GH, Rehman A, Moltzau-Anderson J, Bharti R, Grasis JA, Cassidy L, Tholey A, Fickenscher H, Seegert D, Rosenstiel P, Schreiber S. Efficacy of Sterile Fecal Filtrate Transfer for Treating Patients With Clostridium difficile Infection. Gastroenterology 2017;152:799-811.e7. [PMID: 27866880 DOI: 10.1053/j.gastro.2016.11.010] [Cited by in Crossref: 394] [Cited by in F6Publishing: 403] [Article Influence: 65.7] [Reference Citation Analysis]
|
| 245 |
Nagao-Kitamoto H, Kamada N. Host-microbial Cross-talk in Inflammatory Bowel Disease. Immune Netw 2017;17:1-12. [PMID: 28261015 DOI: 10.4110/in.2017.17.1.1] [Cited by in Crossref: 98] [Cited by in F6Publishing: 101] [Article Influence: 16.3] [Reference Citation Analysis]
|
| 246 |
Mamo G. Anaerobes as Sources of Bioactive Compounds and Health Promoting Tools. Adv Biochem Eng Biotechnol 2016;156:433-64. [PMID: 27432247 DOI: 10.1007/10_2016_6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 247 |
Parashar A, Udayabanu M. Gut microbiota: Implications in Parkinson's disease. Parkinsonism Relat Disord 2017;38:1-7. [PMID: 28202372 DOI: 10.1016/j.parkreldis.2017.02.002] [Cited by in Crossref: 129] [Cited by in F6Publishing: 133] [Article Influence: 21.5] [Reference Citation Analysis]
|
| 248 |
Chu ND, Smith MB, Perrotta AR, Kassam Z, Alm EJ. Profiling Living Bacteria Informs Preparation of Fecal Microbiota Transplantations. PLoS One 2017;12:e0170922. [PMID: 28125667 DOI: 10.1371/journal.pone.0170922] [Cited by in Crossref: 58] [Cited by in F6Publishing: 59] [Article Influence: 9.7] [Reference Citation Analysis]
|
| 249 |
Newman KM, Rank KM, Vaughn BP, Khoruts A. Treatment of recurrent Clostridium difficile infection using fecal microbiota transplantation in patients with inflammatory bowel disease. Gut Microbes 2017;8:303-9. [PMID: 28102756 DOI: 10.1080/19490976.2017.1279377] [Cited by in Crossref: 48] [Cited by in F6Publishing: 54] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 250 |
Rosenstiel P. Molekulare Darmmikrobiomdiagnostik: Einblick in unser anderes Genom. Gastroenterologe 2017;12:49-59. [DOI: 10.1007/s11377-016-0129-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 251 |
Jin B. Fecal microbiota transplantation in ulcerative colitis. Shijie Huaren Xiaohua Zazhi 2017; 25(1): 23-30 [DOI: 10.11569/wcjd.v25.i1.23] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 252 |
Martinez KB, Mackert JD, Mcintosh MK. Polyphenols and Intestinal Health. Nutrition and Functional Foods for Healthy Aging 2017. [DOI: 10.1016/b978-0-12-805376-8.00018-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 253 |
Zielińska M. IBS Patient’s Guide. Introduction to Gastrointestinal Diseases Vol. 1 2017. [DOI: 10.1007/978-3-319-49016-8_5] [Reference Citation Analysis]
|
| 254 |
Al Khodor S, Reichert B, Shatat IF. The Microbiome and Blood Pressure: Can Microbes Regulate Our Blood Pressure? Front Pediatr 2017;5:138. [PMID: 28674682 DOI: 10.3389/fped.2017.00138] [Cited by in Crossref: 79] [Cited by in F6Publishing: 76] [Article Influence: 13.2] [Reference Citation Analysis]
|
| 255 |
Wang AY, Popov J, Pai N. Fecal microbial transplant for the treatment of pediatric inflammatory bowel disease. World J Gastroenterol 2016; 22(47): 10304-10315 [PMID: 28058011 DOI: 10.3748/wjg.v22.i47.10304] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 256 |
Staley C, Vaughn BP, Graiziger CT, Sadowsky MJ, Khoruts A. Gut-sparing treatment of urinary tract infection in patients at high risk of Clostridium difficile infection. J Antimicrob Chemother 2017;72:522-8. [PMID: 27999027 DOI: 10.1093/jac/dkw499] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 257 |
Gong D, Gong X, Wang L, Yu X, Dong Q. Involvement of Reduced Microbial Diversity in Inflammatory Bowel Disease. Gastroenterol Res Pract. 2016;2016:6951091. [PMID: 28074093 DOI: 10.1155/2016/6951091] [Cited by in Crossref: 49] [Cited by in F6Publishing: 53] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 258 |
Bravo-Blas A, Wessel H, Milling S. Microbiota and arthritis: correlations or cause? Curr Opin Rheumatol 2016;28:161-7. [PMID: 26814405 DOI: 10.1097/BOR.0000000000000261] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 259 |
Armstrong CW, Mcgregor NR, Lewis DP, Butt HL, Gooley PR. The association of fecal microbiota and fecal, blood serum and urine metabolites in myalgic encephalomyelitis/chronic fatigue syndrome. Metabolomics 2017;13. [DOI: 10.1007/s11306-016-1145-z] [Cited by in Crossref: 30] [Cited by in F6Publishing: 7] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 260 |
Lin YW, Montassier E, Knights D, Wei LN. Gut microbiota from metabolic disease-resistant, macrophage-specific RIP140 knockdown mice improves metabolic phenotype and gastrointestinal integrity. Sci Rep 2016;6:38599. [PMID: 27929078 DOI: 10.1038/srep38599] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 261 |
Suzuki K, Yoshida K, Nakanishi Y, Fukuda S. An equation-free method reveals the ecological interaction networks within complex microbial ecosystems.. [DOI: 10.1101/080697] [Reference Citation Analysis]
|
| 262 |
Jalanka J, Mattila E, Jouhten H, Hartman J, de Vos WM, Arkkila P, Satokari R. Long-term effects on luminal and mucosal microbiota and commonly acquired taxa in faecal microbiota transplantation for recurrent Clostridium difficile infection. BMC Med 2016;14:155. [PMID: 27724956 DOI: 10.1186/s12916-016-0698-z] [Cited by in Crossref: 73] [Cited by in F6Publishing: 70] [Article Influence: 10.4] [Reference Citation Analysis]
|
| 263 |
Hauptmann M, Schaible UE. Linking microbiota and respiratory disease. FEBS Lett 2016;590:3721-38. [PMID: 27637588 DOI: 10.1002/1873-3468.12421] [Cited by in Crossref: 51] [Cited by in F6Publishing: 54] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 264 |
Hašková K, Dyrhonová M, Boštíková V. FECAL MICROBIOTA THERAPY AND ITS POTENTIAL IN MEDICAL PRACTICE. Mil Med Sci Lett 2016;85:111-120. [DOI: 10.31482/mmsl.2016.020] [Reference Citation Analysis]
|
| 265 |
Khoruts A, Sadowsky MJ. Understanding the mechanisms of faecal microbiota transplantation. Nat Rev Gastroenterol Hepatol 2016;13:508-16. [PMID: 27329806 DOI: 10.1038/nrgastro.2016.98] [Cited by in Crossref: 278] [Cited by in F6Publishing: 267] [Article Influence: 39.7] [Reference Citation Analysis]
|
| 266 |
Weingarden AR, Chen C, Zhang N, Graiziger CT, Dosa PI, Steer CJ, Shaughnessy MK, Johnson JR, Sadowsky MJ, Khoruts A. Ursodeoxycholic Acid Inhibits Clostridium difficile Spore Germination and Vegetative Growth, and Prevents the Recurrence of Ileal Pouchitis Associated With the Infection. J Clin Gastroenterol 2016;50:624-30. [PMID: 26485102 DOI: 10.1097/MCG.0000000000000427] [Cited by in Crossref: 74] [Cited by in F6Publishing: 71] [Article Influence: 10.6] [Reference Citation Analysis]
|
| 267 |
Gallo A, Passaro G, Gasbarrini A, Landolfi R, Montalto M. Modulation of microbiota as treatment for intestinal inflammatory disorders: An uptodate. World J Gastroenterol 2016; 22(32): 7186-7202 [PMID: 27621567 DOI: 10.3748/wjg.v22.i32.7186] [Cited by in CrossRef: 64] [Cited by in F6Publishing: 65] [Article Influence: 9.1] [Reference Citation Analysis]
|
| 268 |
Cheng TL, Mayberry H, Mcguire LP, Hoyt JR, Langwig KE, Nguyen H, Parise KL, Foster JT, Willis CKR, Kilpatrick AM, Frick WF. Efficacy of a probiotic bacterium to treat bats affected by the disease white‐nose syndrome. J Appl Ecol 2017;54:701-8. [DOI: 10.1111/1365-2664.12757] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 269 |
Luczynski P, McVey Neufeld KA, Oriach CS, Clarke G, Dinan TG, Cryan JF. Growing up in a Bubble: Using Germ-Free Animals to Assess the Influence of the Gut Microbiota on Brain and Behavior. Int J Neuropsychopharmacol 2016;19:pyw020. [PMID: 26912607 DOI: 10.1093/ijnp/pyw020] [Cited by in Crossref: 316] [Cited by in F6Publishing: 318] [Article Influence: 45.1] [Reference Citation Analysis]
|
| 270 |
Li M, Li Z, Wen S, Liu Y, Wang Y, Tang L. Transplantation of a bacterial consortium ameliorates trinitrobenzenesulfonic acid-induced colitis and intestinal dysbiosis in rats. Future Microbiol 2016;11:887-902. [PMID: 27415182 DOI: 10.2217/fmb-2015-0002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 271 |
Bojanova DP, Bordenstein SR. Fecal Transplants: What Is Being Transferred? PLoS Biol 2016;14:e1002503. [PMID: 27404502 DOI: 10.1371/journal.pbio.1002503] [Cited by in Crossref: 103] [Cited by in F6Publishing: 105] [Article Influence: 14.7] [Reference Citation Analysis]
|
| 272 |
Brittnacher MJ, Heltshe SL, Hayden HS, Radey MC, Weiss EJ, Damman CJ, Zisman TL, Suskind DL, Miller SI. GUTSS: An Alignment-Free Sequence Comparison Method for Use in Human Intestinal Microbiome and Fecal Microbiota Transplantation Analysis. PLoS One 2016;11:e0158897. [PMID: 27391011 DOI: 10.1371/journal.pone.0158897] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 273 |
Bashan A, Gibson TE, Friedman J, Carey VJ, Weiss ST, Hohmann EL, Liu YY. Universality of human microbial dynamics. Nature. 2016;534:259-262. [PMID: 27279224 DOI: 10.1038/nature18301] [Cited by in Crossref: 175] [Cited by in F6Publishing: 178] [Article Influence: 25.0] [Reference Citation Analysis]
|
| 274 |
Krezalek MA, Skowron KB, Guyton KL, Shakhsheer B, Hyoju S, Alverdy JC. The intestinal microbiome and surgical disease. Curr Probl Surg 2016;53:257-93. [PMID: 27497246 DOI: 10.1067/j.cpsurg.2016.06.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 275 |
Broecker F, Klumpp J, Moelling K. Long-term microbiota and virome in a Zürich patient after fecal transplantation against Clostridium difficile infection. Ann N Y Acad Sci 2016;1372:29-41. [PMID: 27286042 DOI: 10.1111/nyas.13100] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 5.1] [Reference Citation Analysis]
|
| 276 |
Saha P, Yeoh BS, Singh R, Chandrasekar B, Vemula PK, Haribabu B, Vijay-Kumar M, Jala VR. Gut Microbiota Conversion of Dietary Ellagic Acid into Bioactive Phytoceutical Urolithin A Inhibits Heme Peroxidases. PLoS One 2016;11:e0156811. [PMID: 27254317 DOI: 10.1371/journal.pone.0156811] [Cited by in Crossref: 75] [Cited by in F6Publishing: 76] [Article Influence: 10.7] [Reference Citation Analysis]
|
| 277 |
Yadav V, Varum F, Bravo R, Furrer E, Bojic D, Basit AW. Inflammatory bowel disease: exploring gut pathophysiology for novel therapeutic targets. Transl Res 2016;176:38-68. [PMID: 27220087 DOI: 10.1016/j.trsl.2016.04.009] [Cited by in Crossref: 105] [Cited by in F6Publishing: 108] [Article Influence: 15.0] [Reference Citation Analysis]
|
| 278 |
Gupta N, Aggarwal A, Gupta R, Sule S, Wolf DC. The management of eosinophilic gastroenteritis. Scand J Gastroenterol 2015;50:1309-14. [PMID: 26027839 DOI: 10.3109/00365521.2015.1049655] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 279 |
Hensley-McBain T, Zevin AS, Manuzak J, Smith E, Gile J, Miller C, Agricola B, Katze M, Reeves RK, Kraft CS, Langevin S, Klatt NR. Effects of Fecal Microbial Transplantation on Microbiome and Immunity in Simian Immunodeficiency Virus-Infected Macaques. J Virol 2016;90:4981-9. [PMID: 26937040 DOI: 10.1128/JVI.00099-16] [Cited by in Crossref: 65] [Cited by in F6Publishing: 66] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 280 |
Nagao-Kitamoto H, Kitamoto S, Kuffa P, Kamada N. Pathogenic role of the gut microbiota in gastrointestinal diseases. Intest Res. 2016;14:127-138. [PMID: 27175113 DOI: 10.5217/ir.2016.14.2.127] [Cited by in Crossref: 88] [Cited by in F6Publishing: 91] [Article Influence: 12.6] [Reference Citation Analysis]
|
| 281 |
Vermeire S, Joossens M, Verbeke K, Wang J, Machiels K, Sabino J, Ferrante M, Van Assche G, Rutgeerts P, Raes J. Donor Species Richness Determines Faecal Microbiota Transplantation Success in Inflammatory Bowel Disease. J Crohns Colitis 2016;10:387-94. [PMID: 26519463 DOI: 10.1093/ecco-jcc/jjv203] [Cited by in Crossref: 204] [Cited by in F6Publishing: 209] [Article Influence: 29.1] [Reference Citation Analysis]
|
| 282 |
Woloszynek S, Pastor S, Mell JC, Nandi N, Sokhansanj B, Rosen GL. Engineering Human Microbiota: Influencing Cellular and Community Dynamics for Therapeutic Applications. Int Rev Cell Mol Biol 2016;324:67-124. [PMID: 27017007 DOI: 10.1016/bs.ircmb.2016.01.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 283 |
Nie YF, Hu J, Yan XH. Cross-talk between bile acids and intestinal microbiota in host metabolism and health. J Zhejiang Univ Sci B. 2015;16:436-446. [PMID: 26055905 DOI: 10.1631/jzus.b1400327] [Cited by in Crossref: 76] [Cited by in F6Publishing: 79] [Article Influence: 10.9] [Reference Citation Analysis]
|
| 284 |
Gupta S, Allen-Vercoe E, Petrof EO. Fecal microbiota transplantation: in perspective. Therap Adv Gastroenterol 2016;9:229-39. [PMID: 26929784 DOI: 10.1177/1756283X15607414] [Cited by in Crossref: 221] [Cited by in F6Publishing: 221] [Article Influence: 31.6] [Reference Citation Analysis]
|
| 285 |
Salman S, Vardatsikos G, Avard D, Palmour N, Dewar K, Zawati MH. FMT Happens: Regulating Fecal Microbiota Therapy in Canada; What You Need to Know: Regulating FMT in Canada. World Medical & Health Policy 2016;8:95-106. [DOI: 10.1002/wmh3.174] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 286 |
Mullen KR, Yasuda K, Divers TJ, Weese JS. Equine faecal microbiota transplant: Current knowledge, proposed guidelines and future directions. Equine Vet Educ 2018;30:151-60. [PMID: 32313396 DOI: 10.1111/eve.12559] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 287 |
Sadowsky MJ, Khoruts A. Faecal microbiota transplantation is promising but not a panacea. Nat Microbiol 2016;1:16015. [PMID: 27572174 DOI: 10.1038/nmicrobiol.2016.15] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 288 |
Craig JM. Atopic dermatitis and the intestinal microbiota in humans and dogs. Vet Med Sci 2016;2:95-105. [PMID: 29067183 DOI: 10.1002/vms3.24] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 5.1] [Reference Citation Analysis]
|
| 289 |
Sheth RU, Cabral V, Chen SP, Wang HH. Manipulating Bacterial Communities by in situ Microbiome Engineering. Trends Genet. 2016;32:189-200. [PMID: 26916078 DOI: 10.1016/j.tig.2016.01.005] [Cited by in Crossref: 164] [Cited by in F6Publishing: 168] [Article Influence: 23.4] [Reference Citation Analysis]
|
| 290 |
Jayasinghe TN, Chiavaroli V, Holland DJ, Cutfield WS, O'Sullivan JM. The New Era of Treatment for Obesity and Metabolic Disorders: Evidence and Expectations for Gut Microbiome Transplantation. Front Cell Infect Microbiol 2016;6:15. [PMID: 26925392 DOI: 10.3389/fcimb.2016.00015] [Cited by in Crossref: 44] [Cited by in F6Publishing: 48] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 291 |
Mattner J, Schmidt F, Siegmund B. Faecal microbiota transplantation-A clinical view. Int J Med Microbiol 2016;306:310-5. [PMID: 26924753 DOI: 10.1016/j.ijmm.2016.02.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 292 |
Fofanova TY, Petrosino JF, Kellermayer R. Microbiome-Epigenome Interactions and the Environmental Origins of Inflammatory Bowel Diseases. J Pediatr Gastroenterol Nutr 2016;62:208-19. [PMID: 26308318 DOI: 10.1097/MPG.0000000000000950] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 293 |
Weingarden AR, Dosa PI, DeWinter E, Steer CJ, Shaughnessy MK, Johnson JR, Khoruts A, Sadowsky MJ. Changes in Colonic Bile Acid Composition following Fecal Microbiota Transplantation Are Sufficient to Control Clostridium difficile Germination and Growth. PLoS One 2016;11:e0147210. [PMID: 26789728 DOI: 10.1371/journal.pone.0147210] [Cited by in Crossref: 101] [Cited by in F6Publishing: 106] [Article Influence: 14.4] [Reference Citation Analysis]
|
| 294 |
Luczynski P, Mcvey Neufeld K, Clarke G, Dinan T, Cryan J. Germ-Free Animals. The Gut-Brain Axis 2016. [DOI: 10.1016/b978-0-12-802304-4.00007-4] [Reference Citation Analysis]
|
| 295 |
Dowle C. Faecal microbiota transplantation: a review of FMT as an alternative treatment forClostridium difficileinfection. Bioscience Horizons 2016;9:hzw007. [DOI: 10.1093/biohorizons/hzw007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 296 |
Wekerle H, Hohlfeld R. Gut Microbiota in Multiple Sclerosis. Translational Neuroimmunology in Multiple Sclerosis 2016. [DOI: 10.1016/b978-0-12-801914-6.00009-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 297 |
Gu S, Chen Y, Zhang X, Lu H, Lv T, Shen P, Lv L, Zheng B, Jiang X, Li L. Identification of key taxa that favor intestinal colonization of Clostridium difficile in an adult Chinese population. Microbes and Infection 2016;18:30-8. [DOI: 10.1016/j.micinf.2015.09.008] [Cited by in Crossref: 54] [Cited by in F6Publishing: 57] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 298 |
Lockett TJ, Bird AR, Christophersen C, Clarke JM, Conlon MA, Topping DL. Microbes, Metabolites and Health. Microbial Metabolomics 2016. [DOI: 10.1007/978-3-319-46326-1_2] [Reference Citation Analysis]
|
| 299 |
The Gastrointestinal Microbiome. Molecular Microbiology 2016. [DOI: 10.1128/9781555819071.ch11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 300 |
Sorci G, Guivier E, Lippens C, Faivre B. Microbes, Parasites and Immune Diseases. Evolutionary Thinking in Medicine 2016. [DOI: 10.1007/978-3-319-29716-3_15] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 301 |
Leis S, Borody TJ, Jiang C, Campbell J. Fecal microbiota transplantation: A ‘How-To’ guide for nurses. Collegian 2015;22:445-51. [DOI: 10.1016/j.colegn.2014.08.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 302 |
Fond G, Chevalier G, Eberl G, Leboyer M. [The potential role of microbiota in major psychiatric disorders: Mechanisms, preclinical data, gastro-intestinal comorbidities and therapeutic options]. Presse Med 2016;45:7-19. [PMID: 26653939 DOI: 10.1016/j.lpm.2015.10.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 303 |
Mattar M. Fecal Microbiota Transplantation in Recurrent Clostridium Difficile Infections: Our Experience in Patients with and without Inflammatory Bowel Disease. GHOA 2015;3. [DOI: 10.15406/ghoa.2015.03.00071] [Reference Citation Analysis]
|
| 304 |
Nee J, Zakari M, Lembo AJ. Current and emerging drug options in the treatment of diarrhea predominant irritable bowel syndrome. Expert Opin Pharmacother 2015;16:2781-92. [PMID: 26558923 DOI: 10.1517/14656566.2015.1101449] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 305 |
Bakker GJ, Zhao J, Herrema H, Nieuwdorp M. Gut Microbiota and Energy Expenditure in Health and Obesity. J Clin Gastroenterol 2015;49 Suppl 1:S13-9. [PMID: 26447957 DOI: 10.1097/MCG.0000000000000363] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 306 |
Lam K, Schleimer R, Kern RC. The Etiology and Pathogenesis of Chronic Rhinosinusitis: a Review of Current Hypotheses. Curr Allergy Asthma Rep 2015;15:41. [PMID: 26143392 DOI: 10.1007/s11882-015-0540-2] [Cited by in Crossref: 113] [Cited by in F6Publishing: 95] [Article Influence: 14.1] [Reference Citation Analysis]
|
| 307 |
Curtis MM, Hu Z, Klimko C, Narayanan S, Deberardinis R, Sperandio V. The gut commensal Bacteroides thetaiotaomicron exacerbates enteric infection through modification of the metabolic landscape. Cell Host Microbe 2014;16:759-69. [PMID: 25498343 DOI: 10.1016/j.chom.2014.11.005] [Cited by in Crossref: 191] [Cited by in F6Publishing: 196] [Article Influence: 23.9] [Reference Citation Analysis]
|
| 308 |
Lim ES, Zhou Y, Zhao G, Bauer IK, Droit L, Ndao IM, Warner BB, Tarr PI, Wang D, Holtz LR. Early life dynamics of the human gut virome and bacterial microbiome in infants. Nat Med 2015;21:1228-34. [PMID: 26366711 DOI: 10.1038/nm.3950] [Cited by in Crossref: 363] [Cited by in F6Publishing: 372] [Article Influence: 45.4] [Reference Citation Analysis]
|
| 309 |
Damman CJ, Brittnacher MJ, Westerhoff M, Hayden HS, Radey M, Hager KR, Marquis SR, Miller SI, Zisman TL. Low Level Engraftment and Improvement following a Single Colonoscopic Administration of Fecal Microbiota to Patients with Ulcerative Colitis. PLoS One. 2015;10:e0133925. [PMID: 26288277 DOI: 10.1371/journal.pone.0133925] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 5.9] [Reference Citation Analysis]
|
| 310 |
Pérez-Cobas AE, Moya A, Gosalbes MJ, Latorre A. Colonization Resistance of the Gut Microbiota against Clostridium difficile. Antibiotics (Basel) 2015;4:337-57. [PMID: 27025628 DOI: 10.3390/antibiotics4030337] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 311 |
Natividad JM, Pinto-Sanchez MI, Galipeau HJ, Jury J, Jordana M, Reinisch W, Collins SM, Bercik P, Surette MG, Allen-Vercoe E, Verdu EF. Ecobiotherapy Rich in Firmicutes Decreases Susceptibility to Colitis in a Humanized Gnotobiotic Mouse Model. Inflamm Bowel Dis 2015;21:1883-93. [PMID: 26060932 DOI: 10.1097/MIB.0000000000000422] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 312 |
Yan FY, Ju J, Gao F, Wang XQ. Application of fecal microbiota transplantation in inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2015; 23(21): 3406-3412 [DOI: 10.11569/wcjd.v23.i21.3406] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 313 |
Umesaki Y. Use of gnotobiotic mice to identify and characterize key microbes responsible for the development of the intestinal immune system. Proc Jpn Acad Ser B Phys Biol Sci 2014;90:313-32. [PMID: 25391317 DOI: 10.2183/pjab.90.313] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 314 |
Ji B, Nielsen J. From next-generation sequencing to systematic modeling of the gut microbiome. Front Genet 2015;6:219. [PMID: 26157455 DOI: 10.3389/fgene.2015.00219] [Cited by in Crossref: 65] [Cited by in F6Publishing: 73] [Article Influence: 8.1] [Reference Citation Analysis]
|
| 315 |
Freimoser FM, Pelludat C, Remus-Emsermann MN. Tritagonist as a new term for uncharacterised microorganisms in environmental systems. ISME J 2016;10:1-3. [PMID: 26035056 DOI: 10.1038/ismej.2015.92] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 316 |
Li YY. Gut microbiota disturbance and non-alcoholic fatty liver disease. Shijie Huaren Xiaohua Zazhi 2015; 23(15): 2355-2362 [DOI: 10.11569/wcjd.v23.i15.2355] [Reference Citation Analysis]
|
| 317 |
Rosenfeld CS. Microbiome Disturbances and Autism Spectrum Disorders. Drug Metab Dispos 2015;43:1557-71. [PMID: 25852213 DOI: 10.1124/dmd.115.063826] [Cited by in Crossref: 150] [Cited by in F6Publishing: 153] [Article Influence: 18.8] [Reference Citation Analysis]
|
| 318 |
Goodrich JK, Waters JL, Poole AC, Sutter JL, Koren O, Blekhman R, Beaumont M, Van Treuren W, Knight R, Bell JT, Spector TD, Clark AG, Ley RE. Human genetics shape the gut microbiome. Cell. 2014;159:789-799. [PMID: 25417156 DOI: 10.1016/j.cell.2014.09.053] [Cited by in Crossref: 1911] [Cited by in F6Publishing: 1587] [Article Influence: 238.9] [Reference Citation Analysis]
|
| 319 |
Chukkapalli SS, Rivera-Kweh MF, Velsko IM, Chen H, Zheng D, Bhattacharyya I, Gangula PR, Lucas AR, Kesavalu L. Chronic oral infection with major periodontal bacteria Tannerella forsythia modulates systemic atherosclerosis risk factors and inflammatory markers. Pathog Dis 2015;73:ftv009. [PMID: 25663343 DOI: 10.1093/femspd/ftv009] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 320 |
Di Bella S, Gouliouris T, Petrosillo N. Fecal microbiota transplantation (FMT) for Clostridium difficile infection: focus on immunocompromised patients. J Infect Chemother. 2015;21:230-237. [PMID: 25703532 DOI: 10.1016/j.jiac.2015.01.011] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 6.9] [Reference Citation Analysis]
|
| 321 |
Xu MQ, Cao HL, Wang WQ, Wang S, Cao XC, Yan F, Wang BM. Fecal microbiota transplantation broadening its application beyond intestinal disorders. World J Gastroenterol 2015; 21(1): 102-111 [PMID: 25574083 DOI: 10.3748/wjg.v21.i1.102] [Cited by in CrossRef: 154] [Cited by in F6Publishing: 157] [Article Influence: 19.3] [Reference Citation Analysis]
|
| 322 |
Vyas D, Aekka A, Vyas A. Fecal transplant policy and legislation. World J Gastroenterol 2015; 21(1): 6-11 [PMID: 25574076 DOI: 10.3748/wjg.v21.i1.6] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 323 |
Cammarota G, Ianiro G, Cianci R, Bibbò S, Gasbarrini A, Currò D. The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy. Pharmacol Ther 2015;149:191-212. [PMID: 25561343 DOI: 10.1016/j.pharmthera.2014.12.006] [Cited by in Crossref: 115] [Cited by in F6Publishing: 121] [Article Influence: 14.4] [Reference Citation Analysis]
|
| 324 |
Prifti E, Zucker J. The New Science of Metagenomics and the Challenges of Its Use in Both Developed and Developing Countries. In: Morand S, Dujardin J, Lefait-robin R, Apiwathnasorn C, editors. Socio-Ecological Dimensions of Infectious Diseases in Southeast Asia. Singapore: Springer; 2015. pp. 191-216. [DOI: 10.1007/978-981-287-527-3_12] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 325 |
He Y. Bacterial Whole-Genome Determination and Applications. Molecular Medical Microbiology 2015. [DOI: 10.1016/b978-0-12-397169-2.00020-2] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 326 |
Satokari R. Contentious host-microbiota relationship in inflammatory bowel disease--can foes become friends again? Scand J Gastroenterol 2015;50:34-42. [PMID: 25523554 DOI: 10.3109/00365521.2014.966320] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 327 |
Satokari R, Mattila E, Kainulainen V, Arkkila PE. Simple faecal preparation and efficacy of frozen inoculum in faecal microbiota transplantation for recurrent Clostridium difficile infection--an observational cohort study. Aliment Pharmacol Ther 2015;41:46-53. [PMID: 25355279 DOI: 10.1111/apt.13009] [Cited by in Crossref: 99] [Cited by in F6Publishing: 92] [Article Influence: 12.4] [Reference Citation Analysis]
|
| 328 |
Cui B, Feng Q, Wang H, Wang M, Peng Z, Li P, Huang G, Liu Z, Wu P, Fan Z, Ji G, Wang X, Wu K, Fan D, Zhang F. Fecal microbiota transplantation through mid-gut for refractory Crohn's disease: safety, feasibility, and efficacy trial results. J Gastroenterol Hepatol 2015;30:51-8. [PMID: 25168749 DOI: 10.1111/jgh.12727] [Cited by in Crossref: 207] [Cited by in F6Publishing: 211] [Article Influence: 25.9] [Reference Citation Analysis]
|
| 329 |
Kim H, Kang K, Kim S, Im E. Recent Update in Fecal Microbiota Transplantation. The Korean Journal of Microbiology 2014;50:265-274. [DOI: 10.7845/kjm.2014.4072] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 330 |
Ianiro G, Bibbò S, Scaldaferri F, Gasbarrini A, Cammarota G. Fecal microbiota transplantation in inflammatory bowel disease: beyond the excitement. Medicine (Baltimore) 2014;93:e97. [PMID: 25340496 DOI: 10.1097/MD.0000000000000097] [Cited by in Crossref: 59] [Cited by in F6Publishing: 64] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 331 |
Dai YX, Shi CB, Cui BT, Wang M, Ji GZ, Zhang FM. Fecal microbiota transplantation and prednisone for severe eosinophilic gastroenteritis. World J Gastroenterol 2014; 20(43): 16368-16371 [PMID: 25473198 DOI: 10.3748/wjg.v20.i43.16368] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 332 |
Seufferlein T, Kleger A, Nitschmann S. [Recurrent Clostridium difficile infection. Treatment with duodenal infusion of donor feces]. Internist (Berl) 2014;55:455-9. [PMID: 24647687 DOI: 10.1007/s00108-014-3483-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 333 |
Bringiotti R, Ierardi E, Lovero R, Losurdo G, Leo AD, Principi M. Intestinal microbiota: The explosive mixture at the origin of inflammatory bowel disease? World J Gastrointest Pathophysiol 2014; 5(4): 550-559 [PMID: 25400998 DOI: 10.4291/wjgp.v5.i4.550] [Cited by in CrossRef: 49] [Cited by in F6Publishing: 53] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 334 |
Borre YE, Moloney RD, Clarke G, Dinan TG, Cryan JF. The impact of microbiota on brain and behavior: mechanisms & amp; therapeutic potential. Adv Exp Med Biol. 2014;817:373-403. [PMID: 24997043 DOI: 10.1007/978-1-4939-0897-4_17] [Cited by in Crossref: 195] [Cited by in F6Publishing: 151] [Article Influence: 21.7] [Reference Citation Analysis]
|
| 335 |
Tojo R, Suárez A, Clemente MG, de los Reyes-Gavilán CG, Margolles A, Gueimonde M, Ruas-Madiedo P. Intestinal microbiota in health and disease: Role of bifidobacteria in gut homeostasis. World J Gastroenterol 2014; 20(41): 15163-15176 [PMID: 25386066 DOI: 10.3748/wjg.v20.i41.15163] [Cited by in CrossRef: 289] [Cited by in F6Publishing: 299] [Article Influence: 32.1] [Reference Citation Analysis]
|
| 336 |
Fond G, Boukouaci W, Chevalier G, Regnault A, Eberl G, Hamdani N, Dickerson F, Macgregor A, Boyer L, Dargel A. The “psychomicrobiotic”: Targeting microbiota in major psychiatric disorders: A systematic review. Pathol Biol (Paris). 2015;63:35-42. [PMID: 25468489 DOI: 10.1016/j.patbio.2014.10.003] [Cited by in Crossref: 121] [Cited by in F6Publishing: 126] [Article Influence: 13.4] [Reference Citation Analysis]
|
| 337 |
Kaakoush NO, Mitchell HM, Man SM. Role of emerging Campylobacter species in inflammatory bowel diseases. Inflamm Bowel Dis 2014;20:2189-97. [PMID: 24874462 DOI: 10.1097/MIB.0000000000000074] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 338 |
Cammarota G, Ianiro G, Bibbò S, Gasbarrini A. Fecal microbiota transplantation: a new old kid on the block for the management of gut microbiota-related disease. J Clin Gastroenterol 2014;48 Suppl 1:S80-4. [PMID: 25291136 DOI: 10.1097/MCG.0000000000000244] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 339 |
Stilling RM, Bordenstein SR, Dinan TG, Cryan JF. Friends with social benefits: host-microbe interactions as a driver of brain evolution and development? Front Cell Infect Microbiol 2014;4:147. [PMID: 25401092 DOI: 10.3389/fcimb.2014.00147] [Cited by in Crossref: 106] [Cited by in F6Publishing: 110] [Article Influence: 11.8] [Reference Citation Analysis]
|
| 340 |
Guo WT, Dong LN, Wang JP, Liu P. New advances in clinical application of fecal microbiota transplantation. Shijie Huaren Xiaohua Zazhi 2014; 22(30): 4593-4598 [DOI: 10.11569/wcjd.v22.i30.4593] [Reference Citation Analysis]
|
| 341 |
Luciano JA, Zuckerbraun BS. Clostridium difficile infection: prevention, treatment, and surgical management. Surg Clin North Am 2014;94:1335-49. [PMID: 25440127 DOI: 10.1016/j.suc.2014.08.006] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 342 |
DePeters EJ, George LW. Rumen transfaunation. Immunol Lett 2014;162:69-76. [PMID: 25262872 DOI: 10.1016/j.imlet.2014.05.009] [Cited by in Crossref: 66] [Cited by in F6Publishing: 66] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 343 |
Hart AL, Hendy P. The microbiome in inflammatory bowel disease and its modulation as a therapeutic manoeuvre. Proc Nutr Soc. 2014;73:452-456. [PMID: 25221893 DOI: 10.1017/s0029665114001153] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 344 |
Huttenhower C, Kostic AD, Xavier RJ. Inflammatory bowel disease as a model for translating the microbiome. Immunity. 2014;40:843-854. [PMID: 24950204 DOI: 10.1016/j.immuni.2014.05.013] [Cited by in Crossref: 239] [Cited by in F6Publishing: 247] [Article Influence: 26.6] [Reference Citation Analysis]
|
| 345 |
Cammarota G, Ianiro G, Gasbarrini A. Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review. J Clin Gastroenterol 2014;48:693-702. [PMID: 24440934 DOI: 10.1097/MCG.0000000000000046] [Cited by in Crossref: 296] [Cited by in F6Publishing: 293] [Article Influence: 32.9] [Reference Citation Analysis]
|
| 346 |
Qu H, Jiang Z. Clostridium difficile infection in diabetes. Diabetes Research and Clinical Practice 2014;105:285-94. [DOI: 10.1016/j.diabres.2014.06.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 347 |
König J, Brummer R. Alteration of the intestinal microbiota as a cause of and a potential therapeutic option in irritable bowel syndrome. Beneficial Microbes 2014;5:247-61. [DOI: 10.3920/bm2013.0033] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 348 |
Borody TJ, Finlayson S. Fecal microbiota transplantation for Clostridium difficile infection: A surgeon׳s perspective. Seminars in Colon and Rectal Surgery 2014;25:163-166. [DOI: 10.1053/j.scrs.2014.05.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 349 |
de Vos W. Fame and Future of Fecal Transplantations: Developing Next-Generation Therapies with Synthetic Microbiomes. Health and the Gut 2014. [DOI: 10.1201/b17254-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 350 |
Khoruts A, Weingarden AR. Emergence of fecal microbiota transplantation as an approach to repair disrupted microbial gut ecology. Immunol Lett. 2014;162:77-81. [PMID: 25106113 DOI: 10.1016/j.imlet.2014.07.016] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 351 |
Carmody RN, Turnbaugh PJ. Host-microbial interactions in the metabolism of therapeutic and diet-derived xenobiotics. J Clin Invest 2014;124:4173-81. [PMID: 25105361 DOI: 10.1172/JCI72335] [Cited by in Crossref: 180] [Cited by in F6Publishing: 184] [Article Influence: 20.0] [Reference Citation Analysis]
|
| 352 |
D'Haens GR, Sartor RB, Silverberg MS, Petersson J, Rutgeerts P. Future directions in inflammatory bowel disease management. J Crohns Colitis 2014;8:726-34. [PMID: 24742736 DOI: 10.1016/j.crohns.2014.02.025] [Cited by in Crossref: 74] [Cited by in F6Publishing: 80] [Article Influence: 8.2] [Reference Citation Analysis]
|
| 353 |
Brown WR. Fecal microbiota transplantation in treating Clostridium difficile infection. J Dig Dis 2014;15:405-8. [PMID: 24825534 DOI: 10.1111/1751-2980.12160] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 354 |
Borody TJ, Peattie D, Kapur A. Could fecal microbiota transplantation cure all Clostridium difficile infections? Future Microbiol. 2014;9:1-3. [PMID: 24328373 DOI: 10.2217/fmb.13.146] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 355 |
Martin SF. Adaptation in the innate immune system and heterologous innate immunity. Cell Mol Life Sci 2014;71:4115-30. [PMID: 24997561 DOI: 10.1007/s00018-014-1676-2] [Cited by in Crossref: 39] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 356 |
Vaishnavi C. Fecal microbiota transplantation for management of Clostridium difficile infection. Indian J Gastroenterol 2014;33:301-7. [PMID: 24748025 DOI: 10.1007/s12664-014-0459-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 357 |
Samuel BP, Crumb TL, Duba MM. What nurses need to know about fecal microbiota transplantation: education, assessment, and care for children and young adults. J Pediatr Nurs 2014;29:354-61. [PMID: 24582649 DOI: 10.1016/j.pedn.2014.01.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 358 |
Kim JM. [Roles of enteric microbial composition and metabolism in health and diseases]. Korean J Gastroenterol 2013;62:191-205. [PMID: 24162706 DOI: 10.4166/kjg.2013.62.4.191] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 359 |
Gao Z, Kang Y, Yu J, Ren L. Human pharyngeal microbiome may play a protective role in respiratory tract infections. Genomics Proteomics Bioinformatics 2014;12:144-50. [PMID: 24953866 DOI: 10.1016/j.gpb.2014.06.001] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 360 |
de Goffau MC, Fuentes S, van den Bogert B, Honkanen H, de Vos WM, Welling GW, Hyöty H, Harmsen HJ. Aberrant gut microbiota composition at the onset of type 1 diabetes in young children. Diabetologia. 2014;57:1569-1577. [PMID: 24930037 DOI: 10.1007/s00125-014-3274-0] [Cited by in Crossref: 215] [Cited by in F6Publishing: 179] [Article Influence: 23.9] [Reference Citation Analysis]
|
| 361 |
LeBeau S, Khoruts A. Fecal microbiota transplantation: an interview with alexander khoruts. Glob Adv Health Med 2014;3:73-80. [PMID: 24891996 DOI: 10.7453/gahmj.2014.020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 362 |
Clarke G, Stilling RM, Kennedy PJ, Stanton C, Cryan JF, Dinan TG. Minireview: Gut microbiota: the neglected endocrine organ. Mol Endocrinol. 2014;28:1221-1238. [PMID: 24892638 DOI: 10.1210/me.2014-1108] [Cited by in Crossref: 607] [Cited by in F6Publishing: 638] [Article Influence: 67.4] [Reference Citation Analysis]
|
| 363 |
Rico D, Ying Y, Clarke A, Harvatine K. The effect of rumen digesta inoculation on the time course of recovery from classical diet-induced milk fat depression in dairy cows. Journal of Dairy Science 2014;97:3752-60. [DOI: 10.3168/jds.2013-7342] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 364 |
Sha S, Liang J, Chen M, Xu B, Liang C, Wei N, Wu K. Systematic review: faecal microbiota transplantation therapy for digestive and nondigestive disorders in adults and children. Aliment Pharmacol Ther 2014;39:1003-32. [PMID: 24641570 DOI: 10.1111/apt.12699] [Cited by in Crossref: 95] [Cited by in F6Publishing: 93] [Article Influence: 10.6] [Reference Citation Analysis]
|
| 365 |
Petrof EO, Khoruts A. From stool transplants to next-generation microbiota therapeutics. Gastroenterology 2014;146:1573-82. [PMID: 24412527 DOI: 10.1053/j.gastro.2014.01.004] [Cited by in Crossref: 139] [Cited by in F6Publishing: 143] [Article Influence: 15.4] [Reference Citation Analysis]
|
| 366 |
Barzegari A, Saeedi N, Saei AA. Shrinkage of the human core microbiome and a proposal for launching microbiome biobanks. Future Microbiology 2014;9:639-56. [DOI: 10.2217/fmb.14.22] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 367 |
Ehlermann P, Dösch AO, Katus HA. Donor fecal transfer for recurrent Clostridium difficile-associated diarrhea in heart transplantation. The Journal of Heart and Lung Transplantation 2014;33:551-3. [DOI: 10.1016/j.healun.2014.02.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 368 |
Ley RE. Harnessing microbiota to kill a pathogen: the sweet tooth of Clostridium difficile. Nat Med 2014;20:248-9. [PMID: 24603797 DOI: 10.1038/nm.3494] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 369 |
Shankar V, Hamilton MJ, Khoruts A, Kilburn A, Unno T, Paliy O, Sadowsky MJ. Species and genus level resolution analysis of gut microbiota in Clostridium difficile patients following fecal microbiota transplantation. Microbiome 2014;2:13. [PMID: 24855561 DOI: 10.1186/2049-2618-2-13] [Cited by in Crossref: 80] [Cited by in F6Publishing: 82] [Article Influence: 8.9] [Reference Citation Analysis]
|
| 370 |
Tian P, Xu B, Sun H, Li X, Li Z, Wei P. Isolation and gut microbiota modulation of antibiotic-resistant probiotics from human feces. Diagn Microbiol Infect Dis 2014;79:405-12. [PMID: 24820193 DOI: 10.1016/j.diagmicrobio.2014.04.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 371 |
Parekh PJ, Arusi E, Vinik AI, Johnson DA. The role and influence of gut microbiota in pathogenesis and management of obesity and metabolic syndrome. Front Endocrinol (Lausanne). 2014;5:47. [PMID: 24778627 DOI: 10.3389/fendo.2014.00047] [Cited by in Crossref: 59] [Cited by in F6Publishing: 64] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 372 |
Cammarota G, Ianiro G, Bibbò S, Gasbarrini A. Gut microbiota modulation: probiotics, antibiotics or fecal microbiota transplantation? Intern Emerg Med. 2014;9:365-373. [PMID: 24664520 DOI: 10.1007/s11739-014-1069-4] [Cited by in Crossref: 72] [Cited by in F6Publishing: 63] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 373 |
Borody TJ, Paramsothy S, Agrawal G. Fecal microbiota transplantation: indications, methods, evidence, and future directions. Curr Gastroenterol Rep. 2013;15:337. [PMID: 23852569 DOI: 10.1007/s11894-013-0337-1] [Cited by in Crossref: 160] [Cited by in F6Publishing: 138] [Article Influence: 17.8] [Reference Citation Analysis]
|
| 374 |
Shafquat A, Joice R, Simmons SL, Huttenhower C. Functional and phylogenetic assembly of microbial communities in the human microbiome. Trends Microbiol 2014;22:261-6. [PMID: 24618403 DOI: 10.1016/j.tim.2014.01.011] [Cited by in Crossref: 149] [Cited by in F6Publishing: 151] [Article Influence: 16.6] [Reference Citation Analysis]
|
| 375 |
Pfefferle PI, Renz H. Microbial exposure and onset of allergic diseases - potential prevention strategies? Allergol Int 2014;63:3-10. [PMID: 24569150 DOI: 10.2332/allergolint.13-RAI-0671] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 376 |
Fuentes S, van Nood E, Tims S, Heikamp-de Jong I, ter Braak CJ, Keller JJ, Zoetendal EG, de Vos WM. Reset of a critically disturbed microbial ecosystem: faecal transplant in recurrent Clostridium difficile infection. ISME J. 2014;8:1621-1633. [PMID: 24577353 DOI: 10.1038/ismej.2014.13] [Cited by in Crossref: 138] [Cited by in F6Publishing: 139] [Article Influence: 15.3] [Reference Citation Analysis]
|
| 377 |
Weingarden AR, Chen C, Bobr A, Yao D, Lu Y, Nelson VM, Sadowsky MJ, Khoruts A. Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection. Am J Physiol Gastrointest Liver Physiol 2014;306:G310-9. [PMID: 24284963 DOI: 10.1152/ajpgi.00282.2013] [Cited by in Crossref: 283] [Cited by in F6Publishing: 293] [Article Influence: 31.4] [Reference Citation Analysis]
|
| 378 |
McCarthy JJ, McLeod HL, Ginsburg GS. Genomic medicine: a decade of successes, challenges, and opportunities. Sci Transl Med 2013;5:189sr4. [PMID: 23761042 DOI: 10.1126/scitranslmed.3005785] [Cited by in Crossref: 155] [Cited by in F6Publishing: 173] [Article Influence: 17.2] [Reference Citation Analysis]
|
| 379 |
Bourlioux P. Actualité du microbiote intestinal. Annales Pharmaceutiques Françaises 2014;72:15-21. [DOI: 10.1016/j.pharma.2013.09.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 380 |
van Nood E, Speelman P, Nieuwdorp M, Keller J. Fecal microbiota transplantation: facts and controversies. Curr Opin Gastroenterol 2014;30:34-9. [PMID: 24241245 DOI: 10.1097/MOG.0000000000000024] [Cited by in Crossref: 72] [Cited by in F6Publishing: 73] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 381 |
König J, Brummer R. Modulation of the Gut Ecosystem in Irritable Bowel Syndrome. Pharma-Nutrition 2014. [DOI: 10.1007/978-3-319-06151-1_4] [Reference Citation Analysis]
|
| 382 |
Borody TJ, Brandt LJ, Paramsothy S. Therapeutic faecal microbiota transplantation: current status and future developments. Curr Opin Gastroenterol 2014;30:97-105. [PMID: 24257037 DOI: 10.1097/MOG.0000000000000027] [Cited by in Crossref: 87] [Cited by in F6Publishing: 90] [Article Influence: 9.7] [Reference Citation Analysis]
|
| 383 |
Alverdy J, Gilbert J, DeFazio JR, Sadowsky MJ, Chang EB, Morowitz MJ, Teitelbaum DH. Proceedings of the 2013 A.S.P.E.N. Research workshop: the interface between nutrition and the gut microbiome: implications and applications for human health [corrected]. JPEN J Parenter Enteral Nutr 2014;38:167-78. [PMID: 24379111 DOI: 10.1177/0148607113517904] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 384 |
Dodin M, Katz DE. Faecal microbiota transplantation for Clostridium difficile infection. Int J Clin Pract 2014;68:363-8. [DOI: 10.1111/ijcp.12320] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 385 |
Geiger BM, Gras-Miralles B, Ziogas DC, Karagiannis AK, Zhen A, Fraenkel P, Kokkotou E. Intestinal upregulation of melanin-concentrating hormone in TNBS-induced enterocolitis in adult zebrafish. PLoS One. 2013;8:e83194. [PMID: 24376661 DOI: 10.1371/journal.pone.0083194] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 386 |
Landy J, Hart A. The microbiome in inflammatory bowel disease and beyond. Clin Med (Lond) 2013;13 Suppl 6:s29-31. [PMID: 24298178 DOI: 10.7861/clinmedicine.13-6-s29] [Reference Citation Analysis]
|
| 387 |
Moloney RD, Desbonnet L, Clarke G, Dinan TG, Cryan JF. The microbiome: stress, health and disease. Mamm Genome. 2014;25:49-74. [PMID: 24281320 DOI: 10.1007/s00335-013-9488-5] [Cited by in Crossref: 279] [Cited by in F6Publishing: 228] [Article Influence: 27.9] [Reference Citation Analysis]
|
| 388 |
Di Bella S, Drapeau C, García-Almodóvar E, Petrosillo N. Fecal microbiota transplantation: the state of the art. Infect Dis Rep. 2013;5:e13. [PMID: 24470963 DOI: 10.4081/idr.2013.e13] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 389 |
Weingarden AR, Chen C, Bobr A, Yao D, Lu Y, Nelson VM, Sadowsky MJ, Khoruts A. Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection. Am J Physiol Gastrointest Liver Physiol. 2014;306:G310-G319. [PMID: 24284963 DOI: 10.1152/ajpgi.00282] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 390 |
Song Y, Garg S, Girotra M, Maddox C, von Rosenvinge EC, Dutta A, Dutta S, Fricke WF. Microbiota dynamics in patients treated with fecal microbiota transplantation for recurrent Clostridium difficile infection. PLoS One. 2013;8:e81330. [PMID: 24303043 DOI: 10.1371/journal.pone.0081330] [Cited by in Crossref: 140] [Cited by in F6Publishing: 147] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 391 |
Vannette RL, Fukami T. Historical contingency in species interactions: towards niche-based predictions. Ecol Lett 2014;17:115-24. [PMID: 24341984 DOI: 10.1111/ele.12204] [Cited by in Crossref: 161] [Cited by in F6Publishing: 174] [Article Influence: 16.1] [Reference Citation Analysis]
|
| 392 |
Zhang FM, Wang HG, Wang M, Cui BT, Fan ZN, Ji GZ. Fecal microbiota transplantation for severe enterocolonic fistulizing Crohn’s disease. World J Gastroenterol 2013; 19(41): 7213-7216 [PMID: 24222969 DOI: 10.3748/wjg.v19.i41.7213] [Cited by in CrossRef: 84] [Cited by in F6Publishing: 94] [Article Influence: 8.4] [Reference Citation Analysis]
|
| 393 |
Borody TJ, Brandt LJ, Paramsothy S, Agrawal G. Fecal microbiota transplantation: a new standard treatment option for Clostridium difficile infection. Expert Rev Anti Infect Ther. 2013;11:447-449. [PMID: 23627849 DOI: 10.1586/eri.13.26] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 394 |
Smits LP, Bouter KE, de Vos WM, Borody TJ, Nieuwdorp M. Therapeutic potential of fecal microbiota transplantation. Gastroenterology 2013;145:946-53. [PMID: 24018052 DOI: 10.1053/j.gastro.2013.08.058] [Cited by in Crossref: 421] [Cited by in F6Publishing: 432] [Article Influence: 42.1] [Reference Citation Analysis]
|
| 395 |
Radšel A, Andlovic A, Neubauer D, Osredkar D. Infant botulism: first two confirmed cases in Slovenia and literature review. Eur J Paediatr Neurol 2013;17:651-6. [PMID: 23707631 DOI: 10.1016/j.ejpn.2013.04.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 396 |
Koenigsknecht MJ, Young VB. Faecal microbiota transplantation for the treatment of recurrent Clostridium difficile infection: current promise and future needs. Curr Opin Gastroenterol 2013;29:628-32. [PMID: 24100717 DOI: 10.1097/MOG.0b013e328365d326] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 397 |
Wang H, Wang M, Fan Z, Ji G, Zhang F. Possible primary immunodeficiency presenting with gastrointestinal symptoms: Case report and minireview. Exp Ther Med 2013;6:616-8. [PMID: 24137237 DOI: 10.3892/etm.2013.1178] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 398 |
Yu T, Stockmann C, Balch AH, Spigarelli MG, Sherwin CM. Evolution of interventional vancomycin trials in light of new antibiotic development in the USA, 1999-2012. Int J Antimicrob Agents 2014;43:215-22. [PMID: 24183801 DOI: 10.1016/j.ijantimicag.2013.10.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 399 |
Angelberger S, Reinisch W, Makristathis A, Lichtenberger C, Dejaco C, Papay P, Novacek G, Trauner M, Loy A, Berry D. Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation. Am J Gastroenterol 2013;108:1620-30. [PMID: 24060759 DOI: 10.1038/ajg.2013.257] [Cited by in Crossref: 252] [Cited by in F6Publishing: 259] [Article Influence: 25.2] [Reference Citation Analysis]
|
| 400 |
Dasgupta S, Kasper DL. Relevance of commensal microbiota in the treatment and prevention of inflammatory bowel disease. Inflamm Bowel Dis 2013;19:2478-89. [PMID: 23846489 DOI: 10.1097/MIB.0b013e318297d884] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 401 |
Dai C, Zheng CQ, Jiang M, Ma XY, Jiang LJ. Probiotics and irritable bowel syndrome. World J Gastroenterol 2013; 19(36): 5973-5980 [PMID: 24106397 DOI: 10.3748/wjg.v19.i36.5973] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 51] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 402 |
Sanders NL, Bollinger RR, Lee R, Thomas S, Parker W. Appendectomy and Clostridium difficile colitis: Relationships revealed by clinical observations and immunology. World J Gastroenterol 2013; 19(34): 5607-5614 [PMID: 24039352 DOI: 10.3748/wjg.v19.i34.5607] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 40] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 403 |
Vindigni SM, Broussard EK, Surawicz CM. Alteration of the intestinal microbiome: fecal microbiota transplant and probiotics for Clostridium difficile and beyond. Expert Rev Gastroenterol Hepatol 2013;7:615-28. [PMID: 24070153 DOI: 10.1586/17474124.2013.832501] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 404 |
Martinez KB, Chang EB. Interactions Between Diet and Gut Microbes in Inflammatory Bowel Disease. Clinical Nutrition INSIGHT 2013;39:1-5. [DOI: 10.1097/01.nmd.0000434456.52227.bd] [Reference Citation Analysis]
|
| 405 |
Weingarden AR, Hamilton MJ, Sadowsky MJ, Khoruts A. Resolution of severe Clostridium difficile infection following sequential fecal microbiota transplantation. J Clin Gastroenterol 2013;47:735-7. [PMID: 23632358 DOI: 10.1097/MCG.0b013e31829004ae] [Cited by in Crossref: 65] [Cited by in F6Publishing: 66] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 406 |
Bonfrate L, Tack J, Grattagliano I, Cuomo R, Portincasa P. Microbiota in health and irritable bowel syndrome: current knowledge, perspectives and therapeutic options. Scand J Gastroenterol 2013;48:995-1009. [PMID: 23964766 DOI: 10.3109/00365521.2013.799220] [Cited by in Crossref: 47] [Cited by in F6Publishing: 51] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 407 |
Ostaff MJ, Stange EF, Wehkamp J. Antimicrobial peptides and gut microbiota in homeostasis and pathology. EMBO Mol Med. 2013;5:1465-1483. [PMID: 24039130 DOI: 10.1002/emmm.201201773] [Cited by in Crossref: 201] [Cited by in F6Publishing: 208] [Article Influence: 20.1] [Reference Citation Analysis]
|
| 408 |
Petrof EO, Claud EC, Gloor GB, Allen-Vercoe E. Microbial ecosystems therapeutics: a new paradigm in medicine? Benef Microbes. 2013;4:53-65. [PMID: 23257018 DOI: 10.3920/bm2012.0039] [Cited by in Crossref: 87] [Cited by in F6Publishing: 90] [Article Influence: 8.7] [Reference Citation Analysis]
|
| 409 |
Schilderink R, Verseijden C, de Jonge WJ. Dietary inhibitors of histone deacetylases in intestinal immunity and homeostasis. Front Immunol. 2013;4:226. [PMID: 23914191 DOI: 10.3389/fimmu.2013.00226] [Cited by in Crossref: 27] [Cited by in F6Publishing: 47] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 410 |
Hodes RM. Fecal flora reconstitution for amyotrophic lateral sclerosis. J Clin Gastroenterol 2013;47:655. [PMID: 23507766 DOI: 10.1097/MCG.0b013e3182897a14] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 411 |
Borody TJ, Peattie D, Campbell J. Therapeutic Potential of the Human Gastrointestinal Microbiome: Therapeutic Potential of the Gut Microbiome. Drug Dev Res 2013;74:385-92. [DOI: 10.1002/ddr.21093] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 412 |
The ALSUntangled Group. ALS Untangled No. 21: Fecal transplants. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2013;14:482-5. [DOI: 10.3109/21678421.2013.814981] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 413 |
Adamu BO, Lawley TD. Bacteriotherapy for the treatment of intestinal dysbiosis caused by Clostridium difficile infection. Curr Opin Microbiol 2013;16:596-601. [PMID: 23866975 DOI: 10.1016/j.mib.2013.06.009] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 414 |
Collins SM, Kassam Z, Bercik P. The adoptive transfer of behavioral phenotype via the intestinal microbiota: experimental evidence and clinical implications. Curr Opin Microbiol. 2013;16:240-245. [PMID: 23845749 DOI: 10.1016/j.mib.2013.06.004] [Cited by in Crossref: 130] [Cited by in F6Publishing: 140] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 415 |
Boursier J, Rawls JF, Diehl AM. Obese humans with nonalcoholic fatty liver disease display alterations in fecal microbiota and volatile organic compounds. Clin Gastroenterol Hepatol 2013;11:876-8. [PMID: 23628504 DOI: 10.1016/j.cgh.2013.04.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 416 |
Guinane CM, Cotter PD. Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ. Therap Adv Gastroenterol 2013;6:295-308. [PMID: 23814609 DOI: 10.1177/1756283X13482996] [Cited by in Crossref: 499] [Cited by in F6Publishing: 503] [Article Influence: 49.9] [Reference Citation Analysis]
|
| 417 |
Rogers GB, Bruce KD. Challenges and opportunities for faecal microbiota transplantation therapy. Epidemiol Infect 2013;141:2235-42. [PMID: 23735045 DOI: 10.1017/S0950268813001362] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 418 |
Kim BS, Jeon YS, Chun J. Current status and future promise of the human microbiome. Pediatr Gastroenterol Hepatol Nutr 2013;16:71-9. [PMID: 24010110 DOI: 10.5223/pghn.2013.16.2.71] [Cited by in Crossref: 54] [Cited by in F6Publishing: 58] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 419 |
Current World Literature. Current Opinion in Allergy & Clinical Immunology 2013;13:315-320. [DOI: 10.1097/aci.0b013e3283619e49] [Reference Citation Analysis]
|
| 420 |
Kahn SA, Vachon A, Rodriquez D, Goeppinger SR, Surma B, Marks J, Rubin DT. Patient perceptions of fecal microbiota transplantation for ulcerative colitis. Inflamm Bowel Dis 2013;19:1506-13. [PMID: 23624888 DOI: 10.1097/MIB.0b013e318281f520] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 421 |
Allen-Vercoe E, Petrof EO. Artificial stool transplantation: progress towards a safer, more effective and acceptable alternative. Expert Rev Gastroenterol Hepatol 2013;7:291-3. [PMID: 23639085 DOI: 10.1586/egh.13.16] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 422 |
Kamada N, Seo S, Chen GY, Núñez G. Role of the gut microbiota in immunity and inflammatory disease. Nat Rev Immunol 2013;13:321-35. [DOI: 10.1038/nri3430] [Cited by in Crossref: 1303] [Cited by in F6Publishing: 1359] [Article Influence: 130.3] [Reference Citation Analysis]
|
| 423 |
Li L, Liu Z, Yang X, Yan H, Bao S, Fei J. Bioluminescence imaging for IL-1β expression in experimental colitis. J Inflamm (Lond) 2013;10:16. [PMID: 23577872 DOI: 10.1186/1476-9255-10-16] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 424 |
de Vos WM. Fame and future of faecal transplantations--developing next-generation therapies with synthetic microbiomes. Microb Biotechnol. 2013;6:316-325. [PMID: 23574632 DOI: 10.1111/1751-7915.12047] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 425 |
de Vos WM. Fame and future of faecal transplantations--developing next-generation therapies with synthetic microbiomes. Microb Biotechnol. 2013;6:316-325. [PMID: 23574632 DOI: 10.1111/1751-7915] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
|
| 426 |
Horowitz S. Fecal Microbiota Transplantation: A Novel Way to Treat Gastrointestinal Disorders. Alternative and Complementary Therapies 2013;19:83-88. [DOI: 10.1089/act.2013.19202] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 427 |
Kassam Z, Lee CH, Yuan Y, Hunt RH. Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. Am J Gastroenterol 2013;108:500-8. [PMID: 23511459 DOI: 10.1038/ajg.2013.59] [Cited by in Crossref: 617] [Cited by in F6Publishing: 635] [Article Influence: 61.7] [Reference Citation Analysis]
|
| 428 |
Herring J, Chau PL. Interconnected, inhabited and insecure: why bodies should not be property. J Med Ethics 2014;40:39-43. [PMID: 23514934 DOI: 10.1136/medethics-2012-100904] [Cited by in Crossref: 5] [Cited by in F6Publishing: 20] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 429 |
Heimesaat MM, Plickert R, Fischer A, Göbel UB, Bereswill S. Can microbiota transplantation abrogate murine colonization resistance against Campylobacter jejuni? Eur J Microbiol Immunol (Bp) 2013;3:36-43. [PMID: 24265916 DOI: 10.1556/EuJMI.3.2013.1.5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 430 |
Duncan SH, Flint HJ. Probiotics and prebiotics and health in ageing populations. Maturitas 2013;75:44-50. [PMID: 23489554 DOI: 10.1016/j.maturitas.2013.02.004] [Cited by in Crossref: 131] [Cited by in F6Publishing: 137] [Article Influence: 13.1] [Reference Citation Analysis]
|
| 431 |
Guseo A. [The Parkinson puzzle]. Orv Hetil. 2012;153:2060-2069. [PMID: 23261994 DOI: 10.1556/oh.2012.29461] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 432 |
Hamilton MJ, Weingarden AR, Unno T, Khoruts A, Sadowsky MJ. High-throughput DNA sequence analysis reveals stable engraftment of gut microbiota following transplantation of previously frozen fecal bacteria. Gut Microbes 2013;4:125-35. [PMID: 23333862 DOI: 10.4161/gmic.23571] [Cited by in Crossref: 228] [Cited by in F6Publishing: 237] [Article Influence: 22.8] [Reference Citation Analysis]
|
| 433 |
Krediet CJ, Ritchie KB, Paul VJ, Teplitski M. Coral-associated micro-organisms and their roles in promoting coral health and thwarting diseases. Proc Biol Sci 2013;280:20122328. [PMID: 23363627 DOI: 10.1098/rspb.2012.2328] [Cited by in Crossref: 168] [Cited by in F6Publishing: 174] [Article Influence: 16.8] [Reference Citation Analysis]
|
| 434 |
Schachtschneider KM, Yeoman CJ, Isaacson RE, White BA, Schook LB, Pieters M. Modulation of systemic immune responses through commensal gastrointestinal microbiota. PLoS One 2013;8:e53969. [PMID: 23326551 DOI: 10.1371/journal.pone.0053969] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 435 |
Halland M, Talley NJ. New treatments for IBS. Nat Rev Gastroenterol Hepatol 2013;10:13-23. [PMID: 23147658 DOI: 10.1038/nrgastro.2012.207] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 436 |
Aroniadis OC, Brandt LJ. Fecal microbiota transplantation: past, present and future. Curr Opin Gastroenterol 2013;29:79-84. [PMID: 23041678 DOI: 10.1097/MOG.0b013e32835a4b3e] [Cited by in Crossref: 242] [Cited by in F6Publishing: 247] [Article Influence: 24.2] [Reference Citation Analysis]
|
| 437 |
Faintuch J, Souza SAF, Fabris SM, Rosenblatt A, Cecconello I. Disability in the Post-Obese Bariatric Patient: Old and New Problems. Disabling Obesity 2013. [DOI: 10.1007/978-3-642-35972-9_13] [Reference Citation Analysis]
|
| 438 |
Xu X, Xu P, Ma C, Tang J, Zhang X. Gut microbiota, host health, and polysaccharides. Biotechnol Adv. 2013;31:318-337. [PMID: 23280014 DOI: 10.1016/j.biotechadv.2012.12.009] [Cited by in Crossref: 142] [Cited by in F6Publishing: 148] [Article Influence: 12.9] [Reference Citation Analysis]
|
| 439 |
Morens DM, Fauci AS. Emerging infectious diseases in 2012: 20 years after the institute of medicine report. mBio 2012;3:e00494-12. [PMID: 23232716 DOI: 10.1128/mBio.00494-12] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 440 |
Pondrom S. You aren’t who you think you are: microbial cells outnumber human cells 10 to one, and could prove to be new players in transplantation. Am J Transplant 2012;12:3167-8. [PMID: 23198783 DOI: 10.1111/ajt.12039] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 441 |
Rohlke F, Stollman N. Fecal microbiota transplantation in relapsing Clostridium difficile infection. Therap Adv Gastroenterol 2012;5:403-20. [PMID: 23152734 DOI: 10.1177/1756283X12453637] [Cited by in Crossref: 139] [Cited by in F6Publishing: 146] [Article Influence: 12.6] [Reference Citation Analysis]
|
| 442 |
Zhang F, Luo W, Shi Y, Fan Z, Ji G. Should we standardize the 1,700-year-old fecal microbiota transplantation? Am J Gastroenterol 2012;107:1755; author reply p.1755-6. [PMID: 23160295 DOI: 10.1038/ajg.2012.251] [Cited by in Crossref: 345] [Cited by in F6Publishing: 361] [Article Influence: 31.4] [Reference Citation Analysis]
|
| 443 |
Lawley TD, Clare S, Walker AW, Stares MD, Connor TR, Raisen C, Goulding D, Rad R, Schreiber F, Brandt C. Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog. 2012;8:e1002995. [PMID: 23133377 DOI: 10.1371/journal.ppat.1002995] [Cited by in Crossref: 417] [Cited by in F6Publishing: 432] [Article Influence: 37.9] [Reference Citation Analysis]
|
| 444 |
Damman CJ, Miller SI, Surawicz CM, Zisman TL. The microbiome and inflammatory bowel disease: is there a therapeutic role for fecal microbiota transplantation? Am J Gastroenterol 2012;107:1452-9. [PMID: 23034604 DOI: 10.1038/ajg.2012.93] [Cited by in Crossref: 147] [Cited by in F6Publishing: 151] [Article Influence: 13.4] [Reference Citation Analysis]
|
| 445 |
Flint HJ, Scott KP, Louis P, Duncan SH. The role of the gut microbiota in nutrition and health. Nat Rev Gastroenterol Hepatol 2012;9:577-89. [PMID: 22945443 DOI: 10.1038/nrgastro.2012.156] [Cited by in Crossref: 1207] [Cited by in F6Publishing: 1202] [Article Influence: 109.7] [Reference Citation Analysis]
|
| 446 |
Baquero F, Nombela C. The microbiome as a human organ. Clin Microbiol Infect 2012;18 Suppl 4:2-4. [PMID: 22647038 DOI: 10.1111/j.1469-0691.2012.03916.x] [Cited by in Crossref: 206] [Cited by in F6Publishing: 211] [Article Influence: 18.7] [Reference Citation Analysis]
|
| 447 |
Walker AW, Lawley TD. Therapeutic modulation of intestinal dysbiosis. Pharmacol Res. 2013;69:75-86. [PMID: 23017673 DOI: 10.1016/j.phrs.2012.09.008] [Cited by in Crossref: 114] [Cited by in F6Publishing: 88] [Article Influence: 10.4] [Reference Citation Analysis]
|
| 448 |
Anderson JL, Edney RJ, Whelan K. Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease. Aliment Pharmacol Ther 2012;36:503-16. [PMID: 22827693 DOI: 10.1111/j.1365-2036.2012.05220.x] [Cited by in Crossref: 224] [Cited by in F6Publishing: 221] [Article Influence: 20.4] [Reference Citation Analysis]
|
| 449 |
Floch MH. The power of poop: probiotics and fecal microbial transplant. J Clin Gastroenterol 2012;46:625-6. [PMID: 22874805 DOI: 10.1097/MCG.0b013e3182667a93] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 450 |
Harley IT, Karp CL. Obesity and the gut microbiome: Striving for causality. Mol Metab. 2012;1:21-31. [PMID: 24024115 DOI: 10.1016/j.molmet.2012.07.002] [Cited by in Crossref: 69] [Cited by in F6Publishing: 74] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 451 |
Costa MC, Arroyo LG, Allen-Vercoe E, Stämpfli HR, Kim PT, Sturgeon A, Weese JS. Comparison of the fecal microbiota of healthy horses and horses with colitis by high throughput sequencing of the V3-V5 region of the 16S rRNA gene. PLoS One 2012;7:e41484. [PMID: 22859989 DOI: 10.1371/journal.pone.0041484] [Cited by in Crossref: 223] [Cited by in F6Publishing: 232] [Article Influence: 20.3] [Reference Citation Analysis]
|
| 452 |
Pampel SL. Fäkaltransplantation gegen Diabetes? Info Diabetol 2012;6:54-54. [DOI: 10.1007/s15034-012-0086-5] [Reference Citation Analysis]
|
| 453 |
Wang IM, Stone DJ, Nickle D, Loboda A, Puig O, Roberts C. Systems biology approach for new target and biomarker identification. Curr Top Microbiol Immunol 2013;363:169-99. [PMID: 22903568 DOI: 10.1007/82_2012_252] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
|
